activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2147317	CHEMBL922002	Activity of human MRCKbeta kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	107.0	CHEMBL5052	Homo sapiens	Activity	%	107.0
	2147317	CHEMBL922002	Activity of human MRCKbeta kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	107.0	CHEMBL5052	Homo sapiens	Activity	%	107.0
	2470312	CHEMBL992489	Inhibition of MRCKB at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5052	Homo sapiens	INH	%	10.0
	2721657	CHEMBL1057486	Inhibition of MRCKbeta at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	2901657	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901658	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901659	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901660	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901661	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	910.0	CHEMBL5052	Homo sapiens	Kd	nM	910.0
	2901662	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901663	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901664	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901665	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901666	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901667	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901668	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2100.0	CHEMBL5052	Homo sapiens	Kd	nM	2100.0
	2901669	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901670	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901671	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	3300.0	CHEMBL5052	Homo sapiens	Kd	nM	3300.0
	2901672	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901673	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901674	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901675	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901676	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901677	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901678	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901679	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901680	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901681	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901682	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901683	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901684	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901685	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	4200.0	CHEMBL5052	Homo sapiens	Kd	nM	4200.0
	2901686	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	2700.0	CHEMBL5052	Homo sapiens	Kd	nM	2700.0
	2901687	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901688	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901689	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	42.0	CHEMBL5052	Homo sapiens	Kd	nM	42.0
	2901690	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901691	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901692	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901693	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	2901694	CHEMBL1051290	Binding constant for MRCKB kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2500.0	CHEMBL5052	Homo sapiens	Kd	nM	2500.0
	2921257	CHEMBL1048281	Inhibition of MRCKB assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	82.0	CHEMBL5052	Homo sapiens	Activity	%	82.0
	3052547	CHEMBL1050412	Residual activity of CDC42BPB at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL5052	Homo sapiens	Residual activity	%	90.0
	3052799	CHEMBL1047825	Residual activity of CDC42BPB at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	102.0	CHEMBL5052	Homo sapiens	Residual activity	%	102.0
	3054108	CHEMBL1066626	Residual activity of CDC42BPB at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	120.0	CHEMBL5052	Homo sapiens	Residual activity	%	120.0
	3055395	CHEMBL1050412	Residual activity of CDC42BPB at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	100.0	CHEMBL5052	Homo sapiens	Residual activity	%	100.0
	3055647	CHEMBL1047825	Residual activity of CDC42BPB at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	110.0	CHEMBL5052	Homo sapiens	Residual activity	%	110.0
	3056952	CHEMBL1066626	Residual activity of CDC42BPB at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	87.0	CHEMBL5052	Homo sapiens	Residual activity	%	87.0
	3058272	CHEMBL1050412	Residual activity of CDC42BPB at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	99.0	CHEMBL5052	Homo sapiens	Residual activity	%	99.0
	3058524	CHEMBL1047825	Residual activity of CDC42BPB at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	82.0	CHEMBL5052	Homo sapiens	Residual activity	%	82.0
	3072870	CHEMBL1066626	Residual activity of CDC42BPB at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	83.0	CHEMBL5052	Homo sapiens	Residual activity	%	83.0
	3213974	CHEMBL1116722	Inhibition of MRCKbeta at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	0.0	CHEMBL5052	Homo sapiens	INH	%	0.0
	3224774	CHEMBL1102616	Inhibition of MRCKbeta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3225024	CHEMBL1102616	Inhibition of MRCKbeta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3332039	CHEMBL1166577	Inhibition of MRCKB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3333454	CHEMBL1166577	Inhibition of MRCKB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3334859	CHEMBL1166577	Inhibition of MRCKB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3336279	CHEMBL1166577	Inhibition of MRCKB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3337589	CHEMBL1166577	Inhibition of MRCKB at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3338920	CHEMBL1166577	Inhibition of MRCKB at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3339173	CHEMBL1166577	Inhibition of MRCKB at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3340476	CHEMBL1166577	Inhibition of MRCKB at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3341821	CHEMBL1166577	Inhibition of MRCKB at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3343268	CHEMBL1166577	Inhibition of MRCKB at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	3358682	CHEMBL1174924	Inhibition of MRCKB at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	88.0	CHEMBL5052	Homo sapiens	INH	%	88.0
	3359124	CHEMBL1174924	Inhibition of MRCKB at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	67.0	CHEMBL5052	Homo sapiens	INH	%	67.0
	3406870	CHEMBL1219262	Inhibition of MRCKbeta at 3 uM	B	COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCC1CCN(C)CC1)NC2		CHEMBL1215304	=	Inhibition	%	77.0	CHEMBL5052	Homo sapiens	INH	%	77.0
	3443355	CHEMBL1244388	Inhibition of MRCKbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	3.0	CHEMBL5052	Homo sapiens	INH	%	3.0
	3443572	CHEMBL1244388	Inhibition of MRCKbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	-8.0	CHEMBL5052	Homo sapiens	INH	%	-8.0
	3444727	CHEMBL1244388	Inhibition of MRCKbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	-10.0	CHEMBL5052	Homo sapiens	INH	%	-10.0
	3445210	CHEMBL1244523	Binding affinity to MRCKB	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1000.0	CHEMBL5052	Homo sapiens	Kd	nM	1000.0
	3445351	CHEMBL1244388	Inhibition of MRCKbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	-10.0	CHEMBL5052	Homo sapiens	INH	%	-10.0
	3445568	CHEMBL1244388	Inhibition of MRCKbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	6.0	CHEMBL5052	Homo sapiens	INH	%	6.0
	3448515	CHEMBL1244523	Binding affinity to MRCKB	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	3449746	CHEMBL1244523	Binding affinity to MRCKB	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	3450149	CHEMBL1244523	Binding affinity to MRCKB	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	3450366	CHEMBL1244523	Binding affinity to MRCKB	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	3450807	CHEMBL1244523	Binding affinity to MRCKB	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	3451064	CHEMBL1244523	Binding affinity to MRCKB	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	uM	10.0
	3463188	CHEMBL1251727	Inhibition of CDC42 binding protein beta at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	94.0	CHEMBL5052	Homo sapiens	INH	%	94.0
	3463407	CHEMBL1251727	Inhibition of CDC42 binding protein beta at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	3.0	CHEMBL5052	Homo sapiens	INH	%	3.0
	3463951	CHEMBL1251727	Inhibition of CDC42 binding protein beta at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	14.0	CHEMBL5052	Homo sapiens	INH	%	14.0
	3502349	CHEMBL1259720	Inhibition of MRCKbeta at 1 uM	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)C4Cc5ccccc5C4)CC3)c12		CHEMBL1257283	>	Inhibition	%	90.0	CHEMBL5052	Homo sapiens	INH	%	90.0
	3601422	CHEMBL1292330	Inhibition of CDC42 BpB	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	>	IC50	nM	30000.0	CHEMBL5052	Homo sapiens	IC50	uM	30.0
	5120380	CHEMBL1646204	Inhibition of human MRCKbeta at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	106.0	CHEMBL5052	Homo sapiens	INH	%	106.0
	6339940	CHEMBL1826623	Activity of MRCKB kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	77.0	CHEMBL5052	Homo sapiens	Activity	%	77.0
	7567429	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7567917	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7568385	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	1100.0	CHEMBL5052	Homo sapiens	Kd	nM	1100.0
	7568817	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7569420	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7569892	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7570355	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7570782	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7570936	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7571393	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7571869	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7572332	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7572748	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	4800.0	CHEMBL5052	Homo sapiens	Kd	nM	4800.0
	7572917	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7573374	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2100.0	CHEMBL5052	Homo sapiens	Kd	nM	2100.0
	7573850	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7574319	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7574727	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7574895	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7575356	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7575827	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7576292	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7576869	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7577328	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	330.0	CHEMBL5052	Homo sapiens	Kd	nM	330.0
	7577806	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7578239	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7578877	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	95.0	CHEMBL5052	Homo sapiens	Kd	nM	95.0
	7579251	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	910.0	CHEMBL5052	Homo sapiens	Kd	nM	910.0
	7579701	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	3300.0	CHEMBL5052	Homo sapiens	Kd	nM	3300.0
	7580202	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7580605	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2500.0	CHEMBL5052	Homo sapiens	Kd	nM	2500.0
	7581235	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7581620	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7582094	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7582558	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7582958	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7583581	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7583978	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7583981	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7584452	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7584914	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7585318	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7586323	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7586794	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7587248	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7587430	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7587849	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7588302	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7588773	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7589224	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	2700.0	CHEMBL5052	Homo sapiens	Kd	nM	2700.0
	7589395	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	4800.0	CHEMBL5052	Homo sapiens	Kd	nM	4800.0
	7589819	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1000.0	CHEMBL5052	Homo sapiens	Kd	nM	1000.0
	7590286	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7590760	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7591211	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7591368	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7591790	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7592262	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7592735	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7593335	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7593770	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7594242	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7594725	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7595303	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7595747	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7596221	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7596250	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	910.0	CHEMBL5052	Homo sapiens	Kd	nM	910.0
	7596697	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7597275	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7597728	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7598229	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5052	Homo sapiens	Kd	nM	10000.0
	7598671	CHEMBL1908728	Binding constant for MRCKB kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	42.0	CHEMBL5052	Homo sapiens	Kd	nM	42.0
	8061224	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-1.19	CHEMBL5052	Homo sapiens	Inhibition	%	-1.19
	8061401	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	4.11	CHEMBL5052	Homo sapiens	Inhibition	%	4.11
	8061625	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-1.37	CHEMBL5052	Homo sapiens	Inhibition	%	-1.37
	8061732	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.04	CHEMBL5052	Homo sapiens	Inhibition	%	2.04
	8062147	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.99	CHEMBL5052	Homo sapiens	Inhibition	%	0.99
	8062263	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.02	CHEMBL5052	Homo sapiens	Inhibition	%	3.02
	8062649	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	0.37	CHEMBL5052	Homo sapiens	Inhibition	%	0.37
	8062971	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.75	CHEMBL5052	Homo sapiens	Inhibition	%	-0.75
	8063103	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.3	CHEMBL5052	Homo sapiens	Inhibition	%	1.3
	8063494	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.06	CHEMBL5052	Homo sapiens	Inhibition	%	0.06
	8063602	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.08	CHEMBL5052	Homo sapiens	Inhibition	%	1.08
	8063826	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.59	CHEMBL5052	Homo sapiens	Inhibition	%	0.59
	8064008	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-0.8	CHEMBL5052	Homo sapiens	Inhibition	%	-0.8
	8064123	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	14.42	CHEMBL5052	Homo sapiens	Inhibition	%	14.42
	8064347	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	16.99	CHEMBL5052	Homo sapiens	Inhibition	%	16.99
	8064557	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.85	CHEMBL5052	Homo sapiens	Inhibition	%	0.85
	8064695	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.74	CHEMBL5052	Homo sapiens	Inhibition	%	0.74
	8064919	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.74	CHEMBL5052	Homo sapiens	Inhibition	%	1.74
	8065085	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.1	CHEMBL5052	Homo sapiens	Inhibition	%	-0.1
	8065425	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.24	CHEMBL5052	Homo sapiens	Inhibition	%	1.24
	8065600	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.29	CHEMBL5052	Homo sapiens	Inhibition	%	1.29
	8065939	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	62.92	CHEMBL5052	Homo sapiens	Inhibition	%	62.92
	8066149	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.74	CHEMBL5052	Homo sapiens	Inhibition	%	0.74
	8066509	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.06	CHEMBL5052	Homo sapiens	Inhibition	%	1.06
	8066675	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.25	CHEMBL5052	Homo sapiens	Inhibition	%	0.25
	8067023	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	-0.22	CHEMBL5052	Homo sapiens	Inhibition	%	-0.22
	8067198	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.96	CHEMBL5052	Homo sapiens	Inhibition	%	1.96
	8067543	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.99	CHEMBL5052	Homo sapiens	Inhibition	%	1.99
	8067753	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.39	CHEMBL5052	Homo sapiens	Inhibition	%	3.39
	8068112	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.3	CHEMBL5052	Homo sapiens	Inhibition	%	3.3
	8068276	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-1.64	CHEMBL5052	Homo sapiens	Inhibition	%	-1.64
	8068500	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.28	CHEMBL5052	Homo sapiens	Inhibition	%	-0.28
	8068625	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.27	CHEMBL5052	Homo sapiens	Inhibition	%	-0.27
	8068799	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.32	CHEMBL5052	Homo sapiens	Inhibition	%	1.32
	8069023	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.92	CHEMBL5052	Homo sapiens	Inhibition	%	0.92
	8069148	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	4.92	CHEMBL5052	Homo sapiens	Inhibition	%	4.92
	8069443	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	3.6	CHEMBL5052	Homo sapiens	Inhibition	%	3.6
	8069828	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.17	CHEMBL5052	Homo sapiens	Inhibition	%	0.17
	8069954	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.57	CHEMBL5052	Homo sapiens	Inhibition	%	1.57
	8070350	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.62	CHEMBL5052	Homo sapiens	Inhibition	%	1.62
	8070475	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.59	CHEMBL5052	Homo sapiens	Inhibition	%	-0.59
	8070699	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.06	CHEMBL5052	Homo sapiens	Inhibition	%	2.06
	8070773	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	21.59	CHEMBL5052	Homo sapiens	Inhibition	%	21.59
	8071154	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.38	CHEMBL5052	Homo sapiens	Inhibition	%	-0.38
	8071280	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.87	CHEMBL5052	Homo sapiens	Inhibition	%	0.87
	8071504	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.36	CHEMBL5052	Homo sapiens	Inhibition	%	1.36
	8071677	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.27	CHEMBL5052	Homo sapiens	Inhibition	%	1.27
	8072026	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.73	CHEMBL5052	Homo sapiens	Inhibition	%	0.73
	8072107	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.79	CHEMBL5052	Homo sapiens	Inhibition	%	-0.79
	8072116	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.19	CHEMBL5052	Homo sapiens	Inhibition	%	-0.19
	8072340	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.03	CHEMBL5052	Homo sapiens	Inhibition	%	2.03
	8072497	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-0.1	CHEMBL5052	Homo sapiens	Inhibition	%	-0.1
	8072846	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.11	CHEMBL5052	Homo sapiens	Inhibition	%	-1.11
	8073013	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.57	CHEMBL5052	Homo sapiens	Inhibition	%	0.57
	8073362	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.68	CHEMBL5052	Homo sapiens	Inhibition	%	1.68
	8073705	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.36	CHEMBL5052	Homo sapiens	Inhibition	%	1.36
	8073938	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.98	CHEMBL5052	Homo sapiens	Inhibition	%	1.98
	8074090	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.05	CHEMBL5052	Homo sapiens	Inhibition	%	0.05
	8074444	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.24	CHEMBL5052	Homo sapiens	Inhibition	%	1.24
	8074601	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.05	CHEMBL5052	Homo sapiens	Inhibition	%	-0.05
	8074825	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.05	CHEMBL5052	Homo sapiens	Inhibition	%	1.05
	8074952	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.85	CHEMBL5052	Homo sapiens	Inhibition	%	0.85
	8075287	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.96	CHEMBL5052	Homo sapiens	Inhibition	%	0.96
	8075524	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	4.91	CHEMBL5052	Homo sapiens	Inhibition	%	4.91
	8075665	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.15	CHEMBL5052	Homo sapiens	Inhibition	%	0.15
	8075889	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-0.05	CHEMBL5052	Homo sapiens	Inhibition	%	-0.05
	8076031	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.61	CHEMBL5052	Homo sapiens	Inhibition	%	0.61
	8076403	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.02	CHEMBL5052	Homo sapiens	Inhibition	%	1.02
	8076537	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.14	CHEMBL5052	Homo sapiens	Inhibition	%	4.14
	8076863	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.08	CHEMBL5052	Homo sapiens	Inhibition	%	2.08
	8077110	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	20.79	CHEMBL5052	Homo sapiens	Inhibition	%	20.79
	8077462	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-0.92	CHEMBL5052	Homo sapiens	Inhibition	%	-0.92
	8077613	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	2.31	CHEMBL5052	Homo sapiens	Inhibition	%	2.31
	8077980	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.01	CHEMBL5052	Homo sapiens	Inhibition	%	1.01
	8078119	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.18	CHEMBL5052	Homo sapiens	Inhibition	%	0.18
	8078343	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.15	CHEMBL5052	Homo sapiens	Inhibition	%	0.15
	8078445	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.75	CHEMBL5052	Homo sapiens	Inhibition	%	-0.75
	8078695	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	66.16	CHEMBL5052	Homo sapiens	Inhibition	%	66.16
	8079035	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-0.91	CHEMBL5052	Homo sapiens	Inhibition	%	-0.91
	8079193	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.02	CHEMBL5052	Homo sapiens	Inhibition	%	1.02
	8079417	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.59	CHEMBL5052	Homo sapiens	Inhibition	%	3.59
	8079559	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.5	CHEMBL5052	Homo sapiens	Inhibition	%	-0.5
	8079922	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	1.71	CHEMBL5052	Homo sapiens	Inhibition	%	1.71
	8080027	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.17	CHEMBL5052	Homo sapiens	Inhibition	%	1.17
	8080251	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.27	CHEMBL5052	Homo sapiens	Inhibition	%	1.27
	8080279	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	3.62	CHEMBL5052	Homo sapiens	Inhibition	%	3.62
	8080503	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	12.66	CHEMBL5052	Homo sapiens	Inhibition	%	12.66
	8080618	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.54	CHEMBL5052	Homo sapiens	Inhibition	%	0.54
	8081006	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.52	CHEMBL5052	Homo sapiens	Inhibition	%	0.52
	8081141	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.8	CHEMBL5052	Homo sapiens	Inhibition	%	0.8
	8081365	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.73	CHEMBL5052	Homo sapiens	Inhibition	%	0.73
	8081509	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	23.34	CHEMBL5052	Homo sapiens	Inhibition	%	23.34
	8081836	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.02	CHEMBL5052	Homo sapiens	Inhibition	%	2.02
	8082088	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	29.56	CHEMBL5052	Homo sapiens	Inhibition	%	29.56
	8082201	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.8	CHEMBL5052	Homo sapiens	Inhibition	%	0.8
	8082425	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-1.13	CHEMBL5052	Homo sapiens	Inhibition	%	-1.13
	8082598	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.72	CHEMBL5052	Homo sapiens	Inhibition	%	1.72
	8082945	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.97	CHEMBL5052	Homo sapiens	Inhibition	%	0.97
	8083101	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	0.34	CHEMBL5052	Homo sapiens	Inhibition	%	0.34
	8083424	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.84	CHEMBL5052	Homo sapiens	Inhibition	%	0.84
	8083678	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	72.04	CHEMBL5052	Homo sapiens	Inhibition	%	72.04
	8084012	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.3	CHEMBL5052	Homo sapiens	Inhibition	%	1.3
	8084197	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	0.55	CHEMBL5052	Homo sapiens	Inhibition	%	0.55
	8084539	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.04	CHEMBL5052	Homo sapiens	Inhibition	%	1.04
	8084700	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.24	CHEMBL5052	Homo sapiens	Inhibition	%	5.24
	8084924	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.99	CHEMBL5052	Homo sapiens	Inhibition	%	1.99
	8085022	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.32	CHEMBL5052	Homo sapiens	Inhibition	%	1.32
	8085278	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.9	CHEMBL5052	Homo sapiens	Inhibition	%	1.9
	8085610	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.12	CHEMBL5052	Homo sapiens	Inhibition	%	1.12
	8085799	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	7.07	CHEMBL5052	Homo sapiens	Inhibition	%	7.07
	8086023	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.17	CHEMBL5052	Homo sapiens	Inhibition	%	1.17
	8086138	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.67	CHEMBL5052	Homo sapiens	Inhibition	%	1.67
	8086524	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	12.85	CHEMBL5052	Homo sapiens	Inhibition	%	12.85
	8086623	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.86	CHEMBL5052	Homo sapiens	Inhibition	%	0.86
	8086847	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.41	CHEMBL5052	Homo sapiens	Inhibition	%	0.41
	8087058	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.52	CHEMBL5052	Homo sapiens	Inhibition	%	0.52
	8087216	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.7	CHEMBL5052	Homo sapiens	Inhibition	%	-0.7
	8087554	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.73	CHEMBL5052	Homo sapiens	Inhibition	%	0.73
	8087692	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-1.28	CHEMBL5052	Homo sapiens	Inhibition	%	-1.28
	8087916	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.1	CHEMBL5052	Homo sapiens	Inhibition	%	-0.1
	8088058	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.02	CHEMBL5052	Homo sapiens	Inhibition	%	3.02
	8088430	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.3	CHEMBL5052	Homo sapiens	Inhibition	%	1.3
	8088558	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	0.43	CHEMBL5052	Homo sapiens	Inhibition	%	0.43
	8088875	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	10.89	CHEMBL5052	Homo sapiens	Inhibition	%	10.89
	8089227	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	2.2	CHEMBL5052	Homo sapiens	Inhibition	%	2.2
	8089375	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	-0.74	CHEMBL5052	Homo sapiens	Inhibition	%	-0.74
	8089719	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.41	CHEMBL5052	Homo sapiens	Inhibition	%	-0.41
	8089899	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-2.82	CHEMBL5052	Homo sapiens	Inhibition	%	-2.82
	8090123	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.22	CHEMBL5052	Homo sapiens	Inhibition	%	0.22
	8090288	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.33	CHEMBL5052	Homo sapiens	Inhibition	%	2.33
	8090455	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.51	CHEMBL5052	Homo sapiens	Inhibition	%	0.51
	8090679	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.04	CHEMBL5052	Homo sapiens	Inhibition	%	0.04
	8090818	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.58	CHEMBL5052	Homo sapiens	Inhibition	%	-0.58
	8091023	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.05	CHEMBL5052	Homo sapiens	Inhibition	%	0.05
	8091384	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	0.66	CHEMBL5052	Homo sapiens	Inhibition	%	0.66
	8091539	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.23	CHEMBL5052	Homo sapiens	Inhibition	%	0.23
	8091763	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-0.95	CHEMBL5052	Homo sapiens	Inhibition	%	-0.95
	8091879	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.66	CHEMBL5052	Homo sapiens	Inhibition	%	0.66
	8092240	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.81	CHEMBL5052	Homo sapiens	Inhibition	%	-0.81
	8092391	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-0.63	CHEMBL5052	Homo sapiens	Inhibition	%	-0.63
	8092763	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.14	CHEMBL5052	Homo sapiens	Inhibition	%	1.14
	8092892	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.35	CHEMBL5052	Homo sapiens	Inhibition	%	3.35
	8093116	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.7	CHEMBL5052	Homo sapiens	Inhibition	%	0.7
	8093204	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.31	CHEMBL5052	Homo sapiens	Inhibition	%	0.31
	8093568	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	11.1	CHEMBL5052	Homo sapiens	Inhibition	%	11.1
	8093707	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.5	CHEMBL5052	Homo sapiens	Inhibition	%	0.5
	8093931	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.52	CHEMBL5052	Homo sapiens	Inhibition	%	-0.52
	8094051	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.3	CHEMBL5052	Homo sapiens	Inhibition	%	0.3
	8094455	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.72	CHEMBL5052	Homo sapiens	Inhibition	%	-0.72
	8094630	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.18	CHEMBL5052	Homo sapiens	Inhibition	%	1.18
	8095010	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.72	CHEMBL5052	Homo sapiens	Inhibition	%	0.72
	8095150	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-2.72	CHEMBL5052	Homo sapiens	Inhibition	%	-2.72
	8095353	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.22	CHEMBL5052	Homo sapiens	Inhibition	%	1.22
	8095577	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.13	CHEMBL5052	Homo sapiens	Inhibition	%	0.13
	8095718	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	4.44	CHEMBL5052	Homo sapiens	Inhibition	%	4.44
	8096090	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-0.76	CHEMBL5052	Homo sapiens	Inhibition	%	-0.76
	8096207	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.54	CHEMBL5052	Homo sapiens	Inhibition	%	0.54
	8096431	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	-0.47	CHEMBL5052	Homo sapiens	Inhibition	%	-0.47
	8096570	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.47	CHEMBL5052	Homo sapiens	Inhibition	%	0.47
	8096726	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.8	CHEMBL5052	Homo sapiens	Inhibition	%	2.8
	8096950	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	-0.49	CHEMBL5052	Homo sapiens	Inhibition	%	-0.49
	8097097	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.28	CHEMBL5052	Homo sapiens	Inhibition	%	1.28
	8097404	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.86	CHEMBL5052	Homo sapiens	Inhibition	%	1.86
	8097628	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.92	CHEMBL5052	Homo sapiens	Inhibition	%	0.92
	8097778	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	48.5	CHEMBL5052	Homo sapiens	Inhibition	%	48.5
	8098135	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.21	CHEMBL5052	Homo sapiens	Inhibition	%	-1.21
	8098255	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.37	CHEMBL5052	Homo sapiens	Inhibition	%	-0.37
	8098479	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.51	CHEMBL5052	Homo sapiens	Inhibition	%	0.51
	8098659	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.9	CHEMBL5052	Homo sapiens	Inhibition	%	0.9
	8098844	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	16.41	CHEMBL5052	Homo sapiens	Inhibition	%	16.41
	8099212	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.14	CHEMBL5052	Homo sapiens	Inhibition	%	1.14
	8099354	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.33	CHEMBL5052	Homo sapiens	Inhibition	%	0.33
	8099578	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.86	CHEMBL5052	Homo sapiens	Inhibition	%	0.86
	8099772	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.52	CHEMBL5052	Homo sapiens	Inhibition	%	0.52
	8099919	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.06	CHEMBL5052	Homo sapiens	Inhibition	%	1.06
	8100289	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.26	CHEMBL5052	Homo sapiens	Inhibition	%	0.26
	8100629	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-1.06	CHEMBL5052	Homo sapiens	Inhibition	%	-1.06
	8100769	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.33	CHEMBL5052	Homo sapiens	Inhibition	%	-0.33
	8101153	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.83	CHEMBL5052	Homo sapiens	Inhibition	%	2.83
	8101295	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.08	CHEMBL5052	Homo sapiens	Inhibition	%	0.08
	8101704	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.24	CHEMBL5052	Homo sapiens	Inhibition	%	3.24
	8101957	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	5.25	CHEMBL5052	Homo sapiens	Inhibition	%	5.25
	8102112	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.71	CHEMBL5052	Homo sapiens	Inhibition	%	0.71
	8102467	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.21	CHEMBL5052	Homo sapiens	Inhibition	%	-0.21
	8102811	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.78	CHEMBL5052	Homo sapiens	Inhibition	%	-0.78
	8102989	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.9	CHEMBL5052	Homo sapiens	Inhibition	%	-0.9
	8103185	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.04	CHEMBL5052	Homo sapiens	Inhibition	%	3.04
	8103409	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	26.58	CHEMBL5052	Homo sapiens	Inhibition	%	26.58
	8103547	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.04	CHEMBL5052	Homo sapiens	Inhibition	%	0.04
	8103921	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.75	CHEMBL5052	Homo sapiens	Inhibition	%	0.75
	8104106	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.72	CHEMBL5052	Homo sapiens	Inhibition	%	-0.72
	8104254	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.73	CHEMBL5052	Homo sapiens	Inhibition	%	1.73
	8104478	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.18	CHEMBL5052	Homo sapiens	Inhibition	%	1.18
	8104624	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	6.65	CHEMBL5052	Homo sapiens	Inhibition	%	6.65
	8104962	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.02	CHEMBL5052	Homo sapiens	Inhibition	%	0.02
	8105102	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.68	CHEMBL5052	Homo sapiens	Inhibition	%	0.68
	8105326	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.34	CHEMBL5052	Homo sapiens	Inhibition	%	1.34
	8105492	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	0.19	CHEMBL5052	Homo sapiens	Inhibition	%	0.19
	8105630	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.86	CHEMBL5052	Homo sapiens	Inhibition	%	0.86
	8105854	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-0.81	CHEMBL5052	Homo sapiens	Inhibition	%	-0.81
	8105910	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.53	CHEMBL5052	Homo sapiens	Inhibition	%	1.53
	8106134	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.93	CHEMBL5052	Homo sapiens	Inhibition	%	1.93
	8106299	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.48	CHEMBL5052	Homo sapiens	Inhibition	%	0.48
	8106455	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	3.5	CHEMBL5052	Homo sapiens	Inhibition	%	3.5
	8106679	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	6.58	CHEMBL5052	Homo sapiens	Inhibition	%	6.58
	8106808	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.04	CHEMBL5052	Homo sapiens	Inhibition	%	-0.04
	8107153	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.56	CHEMBL5052	Homo sapiens	Inhibition	%	-0.56
	8107325	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.07	CHEMBL5052	Homo sapiens	Inhibition	%	0.07
	8107750	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.54	CHEMBL5052	Homo sapiens	Inhibition	%	0.54
	8107885	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.43	CHEMBL5052	Homo sapiens	Inhibition	%	1.43
	8108267	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-0.54	CHEMBL5052	Homo sapiens	Inhibition	%	-0.54
	8108442	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-1.4	CHEMBL5052	Homo sapiens	Inhibition	%	-1.4
	8108813	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.35	CHEMBL5052	Homo sapiens	Inhibition	%	1.35
	8108955	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.42	CHEMBL5052	Homo sapiens	Inhibition	%	0.42
	8109179	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.18	CHEMBL5052	Homo sapiens	Inhibition	%	1.18
	8109293	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-0.78	CHEMBL5052	Homo sapiens	Inhibition	%	-0.78
	8109647	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.43	CHEMBL5052	Homo sapiens	Inhibition	%	0.43
	8109818	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.98	CHEMBL5052	Homo sapiens	Inhibition	%	2.98
	8110174	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	0.65	CHEMBL5052	Homo sapiens	Inhibition	%	0.65
	8110453	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.37	CHEMBL5052	Homo sapiens	Inhibition	%	1.37
	8110619	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.09	CHEMBL5052	Homo sapiens	Inhibition	%	1.09
	8111001	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	23.42	CHEMBL5052	Homo sapiens	Inhibition	%	23.42
	8111124	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.03	CHEMBL5052	Homo sapiens	Inhibition	%	0.03
	8111348	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.65	CHEMBL5052	Homo sapiens	Inhibition	%	0.65
	8111475	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.11	CHEMBL5052	Homo sapiens	Inhibition	%	2.11
	8111641	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.13	CHEMBL5052	Homo sapiens	Inhibition	%	0.13
	8111865	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.21	CHEMBL5052	Homo sapiens	Inhibition	%	0.21
	8112070	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.56	CHEMBL5052	Homo sapiens	Inhibition	%	4.56
	8112207	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.02	CHEMBL5052	Homo sapiens	Inhibition	%	0.02
	8112431	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.47	CHEMBL5052	Homo sapiens	Inhibition	%	-0.47
	8112599	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	0.86	CHEMBL5052	Homo sapiens	Inhibition	%	0.86
	8112771	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.65	CHEMBL5052	Homo sapiens	Inhibition	%	-0.65
	8112995	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-2.47	CHEMBL5052	Homo sapiens	Inhibition	%	-2.47
	8113147	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	-0.48	CHEMBL5052	Homo sapiens	Inhibition	%	-0.48
	8113507	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.86	CHEMBL5052	Homo sapiens	Inhibition	%	0.86
	8113631	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-0.41	CHEMBL5052	Homo sapiens	Inhibition	%	-0.41
	8113971	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.31	CHEMBL5052	Homo sapiens	Inhibition	%	-0.31
	8114147	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.69	CHEMBL5052	Homo sapiens	Inhibition	%	0.69
	8114371	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.0	CHEMBL5052	Homo sapiens	Inhibition	%	2.0
	8114503	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-0.66	CHEMBL5052	Homo sapiens	Inhibition	%	-0.66
	8114779	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.51	CHEMBL5052	Homo sapiens	Inhibition	%	1.51
	8114945	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.53	CHEMBL5052	Homo sapiens	Inhibition	%	0.53
	8115169	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.77	CHEMBL5052	Homo sapiens	Inhibition	%	0.77
	8115334	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.72	CHEMBL5052	Homo sapiens	Inhibition	%	0.72
	8115678	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.31	CHEMBL5052	Homo sapiens	Inhibition	%	-0.31
	8115811	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	19.53	CHEMBL5052	Homo sapiens	Inhibition	%	19.53
	8116194	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	1.07	CHEMBL5052	Homo sapiens	Inhibition	%	1.07
	8116397	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.8	CHEMBL5052	Homo sapiens	Inhibition	%	2.8
	8116755	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.17	CHEMBL5052	Homo sapiens	Inhibition	%	-0.17
	8116927	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	0.71	CHEMBL5052	Homo sapiens	Inhibition	%	0.71
	8117322	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.54	CHEMBL5052	Homo sapiens	Inhibition	%	0.54
	8117480	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.36	CHEMBL5052	Homo sapiens	Inhibition	%	2.36
	8117834	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.8	CHEMBL5052	Homo sapiens	Inhibition	%	0.8
	8117972	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.68	CHEMBL5052	Homo sapiens	Inhibition	%	-0.68
	8118196	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.35	CHEMBL5052	Homo sapiens	Inhibition	%	-0.35
	8118312	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	-0.26	CHEMBL5052	Homo sapiens	Inhibition	%	-0.26
	8118708	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	0.49	CHEMBL5052	Homo sapiens	Inhibition	%	0.49
	8118844	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-0.82	CHEMBL5052	Homo sapiens	Inhibition	%	-0.82
	8119115	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.26	CHEMBL5052	Homo sapiens	Inhibition	%	-0.26
	8119498	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.02	CHEMBL5052	Homo sapiens	Inhibition	%	1.02
	8119665	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.16	CHEMBL5052	Homo sapiens	Inhibition	%	3.16
	8120008	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.48	CHEMBL5052	Homo sapiens	Inhibition	%	-0.48
	8120147	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.19	CHEMBL5052	Homo sapiens	Inhibition	%	0.19
	8120371	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.96	CHEMBL5052	Homo sapiens	Inhibition	%	0.96
	8120531	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.65	CHEMBL5052	Homo sapiens	Inhibition	%	-0.65
	8120732	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	22.46	CHEMBL5052	Homo sapiens	Inhibition	%	22.46
	8121084	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.37	CHEMBL5052	Homo sapiens	Inhibition	%	-1.37
	8121256	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.54	CHEMBL5052	Homo sapiens	Inhibition	%	1.54
	8121480	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.12	CHEMBL5052	Homo sapiens	Inhibition	%	4.12
	8121647	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.31	CHEMBL5052	Homo sapiens	Inhibition	%	0.31
	8121810	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	-1.16	CHEMBL5052	Homo sapiens	Inhibition	%	-1.16
	8122034	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	0.28	CHEMBL5052	Homo sapiens	Inhibition	%	0.28
	8122155	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.08	CHEMBL5052	Homo sapiens	Inhibition	%	-0.08
	8122517	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	0.46	CHEMBL5052	Homo sapiens	Inhibition	%	0.46
	8122637	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.36	CHEMBL5052	Homo sapiens	Inhibition	%	2.36
	8122861	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	-0.26	CHEMBL5052	Homo sapiens	Inhibition	%	-0.26
	8123028	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.94	CHEMBL5052	Homo sapiens	Inhibition	%	3.94
	8123170	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-0.23	CHEMBL5052	Homo sapiens	Inhibition	%	-0.23
	8123394	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-0.14	CHEMBL5052	Homo sapiens	Inhibition	%	-0.14
	8123448	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.65	CHEMBL5052	Homo sapiens	Inhibition	%	1.65
	8123672	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.97	CHEMBL5052	Homo sapiens	Inhibition	%	0.97
	8123822	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.48	CHEMBL5052	Homo sapiens	Inhibition	%	2.48
	8123989	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.38	CHEMBL5052	Homo sapiens	Inhibition	%	0.38
	8124213	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.7	CHEMBL5052	Homo sapiens	Inhibition	%	0.7
	8124332	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-1.65	CHEMBL5052	Homo sapiens	Inhibition	%	-1.65
	8124695	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.3	CHEMBL5052	Homo sapiens	Inhibition	%	0.3
	8124860	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-2.08	CHEMBL5052	Homo sapiens	Inhibition	%	-2.08
	8125061	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	0.41	CHEMBL5052	Homo sapiens	Inhibition	%	0.41
	8125285	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.65	CHEMBL5052	Homo sapiens	Inhibition	%	4.65
	8125415	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.62	CHEMBL5052	Homo sapiens	Inhibition	%	0.62
	8125807	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-0.09	CHEMBL5052	Homo sapiens	Inhibition	%	-0.09
	8125971	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.8	CHEMBL5052	Homo sapiens	Inhibition	%	0.8
	8126359	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.71	CHEMBL5052	Homo sapiens	Inhibition	%	0.71
	8126474	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.99	CHEMBL5052	Homo sapiens	Inhibition	%	-0.99
	8126834	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	5.66	CHEMBL5052	Homo sapiens	Inhibition	%	5.66
	8127180	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.5	CHEMBL5052	Homo sapiens	Inhibition	%	1.5
	8127347	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	0.15	CHEMBL5052	Homo sapiens	Inhibition	%	0.15
	8127713	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	0.84	CHEMBL5052	Homo sapiens	Inhibition	%	0.84
	8128001	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.86	CHEMBL5052	Homo sapiens	Inhibition	%	1.86
	8128153	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.83	CHEMBL5052	Homo sapiens	Inhibition	%	0.83
	8128544	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.05	CHEMBL5052	Homo sapiens	Inhibition	%	-0.05
	8128663	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-1.51	CHEMBL5052	Homo sapiens	Inhibition	%	-1.51
	8128887	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-1.16	CHEMBL5052	Homo sapiens	Inhibition	%	-1.16
	8129024	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.29	CHEMBL5052	Homo sapiens	Inhibition	%	0.29
	8129195	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.99	CHEMBL5052	Homo sapiens	Inhibition	%	-0.99
	8129419	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-2.76	CHEMBL5052	Homo sapiens	Inhibition	%	-2.76
	8129608	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-0.06	CHEMBL5052	Homo sapiens	Inhibition	%	-0.06
	8129747	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.7	CHEMBL5052	Homo sapiens	Inhibition	%	0.7
	8129971	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.33	CHEMBL5052	Homo sapiens	Inhibition	%	1.33
	8130132	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-0.68	CHEMBL5052	Homo sapiens	Inhibition	%	-0.68
	8130304	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.36	CHEMBL5052	Homo sapiens	Inhibition	%	-0.36
	8130688	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.53	CHEMBL5052	Homo sapiens	Inhibition	%	4.53
	8130804	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.83	CHEMBL5052	Homo sapiens	Inhibition	%	-0.83
	8131028	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.05	CHEMBL5052	Homo sapiens	Inhibition	%	0.05
	8131167	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.16	CHEMBL5052	Homo sapiens	Inhibition	%	1.16
	8131511	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.07	CHEMBL5052	Homo sapiens	Inhibition	%	0.07
	8131678	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	0.78	CHEMBL5052	Homo sapiens	Inhibition	%	0.78
	8132043	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.21	CHEMBL5052	Homo sapiens	Inhibition	%	1.21
	8132329	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.08	CHEMBL5052	Homo sapiens	Inhibition	%	1.08
	8132476	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.36	CHEMBL5052	Homo sapiens	Inhibition	%	1.36
	8132700	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	5.81	CHEMBL5052	Homo sapiens	Inhibition	%	5.81
	8132868	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.26	CHEMBL5052	Homo sapiens	Inhibition	%	0.26
	8133213	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.3	CHEMBL5052	Homo sapiens	Inhibition	%	0.3
	8133351	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.12	CHEMBL5052	Homo sapiens	Inhibition	%	0.12
	8133747	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.23	CHEMBL5052	Homo sapiens	Inhibition	%	0.23
	8133927	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.61	CHEMBL5052	Homo sapiens	Inhibition	%	3.61
	8134299	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.07	CHEMBL5052	Homo sapiens	Inhibition	%	-0.07
	8134459	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.56	CHEMBL5052	Homo sapiens	Inhibition	%	-0.56
	8134643	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.24	CHEMBL5052	Homo sapiens	Inhibition	%	0.24
	8134867	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.45	CHEMBL5052	Homo sapiens	Inhibition	%	-0.45
	8135027	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.75	CHEMBL5052	Homo sapiens	Inhibition	%	0.75
	8135366	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-0.98	CHEMBL5052	Homo sapiens	Inhibition	%	-0.98
	8135507	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.68	CHEMBL5052	Homo sapiens	Inhibition	%	0.68
	8135731	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	-0.28	CHEMBL5052	Homo sapiens	Inhibition	%	-0.28
	8135852	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.76	CHEMBL5052	Homo sapiens	Inhibition	%	1.76
	8136020	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-0.8	CHEMBL5052	Homo sapiens	Inhibition	%	-0.8
	8136244	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.84	CHEMBL5052	Homo sapiens	Inhibition	%	0.84
	8136388	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.96	CHEMBL5052	Homo sapiens	Inhibition	%	0.96
	8136678	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.21	CHEMBL5052	Homo sapiens	Inhibition	%	1.21
	8137037	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	34.96	CHEMBL5052	Homo sapiens	Inhibition	%	34.96
	8137200	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-0.11	CHEMBL5052	Homo sapiens	Inhibition	%	-0.11
	8137544	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.27	CHEMBL5052	Homo sapiens	Inhibition	%	-0.27
	8137692	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.92	CHEMBL5052	Homo sapiens	Inhibition	%	0.92
	8138082	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.14	CHEMBL5052	Homo sapiens	Inhibition	%	-0.14
	8138261	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.6	CHEMBL5052	Homo sapiens	Inhibition	%	-0.6
	8138633	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.15	CHEMBL5052	Homo sapiens	Inhibition	%	0.15
	8138791	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-1.77	CHEMBL5052	Homo sapiens	Inhibition	%	-1.77
	8139200	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-0.53	CHEMBL5052	Homo sapiens	Inhibition	%	-0.53
	8139359	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.41	CHEMBL5052	Homo sapiens	Inhibition	%	0.41
	8139697	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-1.25	CHEMBL5052	Homo sapiens	Inhibition	%	-1.25
	8140062	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	-0.43	CHEMBL5052	Homo sapiens	Inhibition	%	-0.43
	8140185	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.85	CHEMBL5052	Homo sapiens	Inhibition	%	0.85
	8140568	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-1.06	CHEMBL5052	Homo sapiens	Inhibition	%	-1.06
	8140711	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.94	CHEMBL5052	Homo sapiens	Inhibition	%	2.94
	8140935	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.71	CHEMBL5052	Homo sapiens	Inhibition	%	0.71
	8141013	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.86	CHEMBL5052	Homo sapiens	Inhibition	%	0.86
	8141367	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.63	CHEMBL5052	Homo sapiens	Inhibition	%	0.63
	8141527	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.92	CHEMBL5052	Homo sapiens	Inhibition	%	0.92
	8141751	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.43	CHEMBL5052	Homo sapiens	Inhibition	%	0.43
	8141870	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.99	CHEMBL5052	Homo sapiens	Inhibition	%	-0.99
	8142031	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.2	CHEMBL5052	Homo sapiens	Inhibition	%	0.2
	8142255	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.0	CHEMBL5052	Homo sapiens	Inhibition	%	0.0
	8142423	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.07	CHEMBL5052	Homo sapiens	Inhibition	%	0.07
	8142599	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.82	CHEMBL5052	Homo sapiens	Inhibition	%	0.82
	8142823	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.84	CHEMBL5052	Homo sapiens	Inhibition	%	0.84
	8142972	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.39	CHEMBL5052	Homo sapiens	Inhibition	%	0.39
	8143127	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.04	CHEMBL5052	Homo sapiens	Inhibition	%	1.04
	8143351	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.18	CHEMBL5052	Homo sapiens	Inhibition	%	1.18
	8143538	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.27	CHEMBL5052	Homo sapiens	Inhibition	%	1.27
	8143697	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.83	CHEMBL5052	Homo sapiens	Inhibition	%	0.83
	8143921	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.46	CHEMBL5052	Homo sapiens	Inhibition	%	1.46
	8144035	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.18	CHEMBL5052	Homo sapiens	Inhibition	%	-0.18
	8144398	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-0.83	CHEMBL5052	Homo sapiens	Inhibition	%	-0.83
	8144528	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.0	CHEMBL5052	Homo sapiens	Inhibition	%	2.0
	8144752	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.2	CHEMBL5052	Homo sapiens	Inhibition	%	1.2
	8144905	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-0.2	CHEMBL5052	Homo sapiens	Inhibition	%	-0.2
	8145266	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	-0.02	CHEMBL5052	Homo sapiens	Inhibition	%	-0.02
	8145355	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.27	CHEMBL5052	Homo sapiens	Inhibition	%	1.27
	8145579	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.52	CHEMBL5052	Homo sapiens	Inhibition	%	0.52
	8145703	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.54	CHEMBL5052	Homo sapiens	Inhibition	%	3.54
	8146088	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.92	CHEMBL5052	Homo sapiens	Inhibition	%	0.92
	8146208	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.23	CHEMBL5052	Homo sapiens	Inhibition	%	-0.23
	8146592	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.68	CHEMBL5052	Homo sapiens	Inhibition	%	-0.68
	8146759	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.75	CHEMBL5052	Homo sapiens	Inhibition	%	0.75
	8147152	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	12.67	CHEMBL5052	Homo sapiens	Inhibition	%	12.67
	8147294	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.14	CHEMBL5052	Homo sapiens	Inhibition	%	0.14
	8147671	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.66	CHEMBL5052	Homo sapiens	Inhibition	%	0.66
	8147858	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-0.51	CHEMBL5052	Homo sapiens	Inhibition	%	-0.51
	8148240	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	-0.11	CHEMBL5052	Homo sapiens	Inhibition	%	-0.11
	8148354	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.76	CHEMBL5052	Homo sapiens	Inhibition	%	-0.76
	8148578	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.97	CHEMBL5052	Homo sapiens	Inhibition	%	0.97
	8148717	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.64	CHEMBL5052	Homo sapiens	Inhibition	%	0.64
	8149079	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.3	CHEMBL5052	Homo sapiens	Inhibition	%	2.3
	8149238	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.05	CHEMBL5052	Homo sapiens	Inhibition	%	-0.05
	8149596	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	23.26	CHEMBL5052	Homo sapiens	Inhibition	%	23.26
	8149918	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.49	CHEMBL5052	Homo sapiens	Inhibition	%	2.49
	8150043	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.48	CHEMBL5052	Homo sapiens	Inhibition	%	1.48
	8150427	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.81	CHEMBL5052	Homo sapiens	Inhibition	%	-0.81
	8150547	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-1.0	CHEMBL5052	Homo sapiens	Inhibition	%	-1.0
	8150771	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.17	CHEMBL5052	Homo sapiens	Inhibition	%	-0.17
	8150936	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.44	CHEMBL5052	Homo sapiens	Inhibition	%	-0.44
	8151099	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.35	CHEMBL5052	Homo sapiens	Inhibition	%	0.35
	8151323	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	5.75	CHEMBL5052	Homo sapiens	Inhibition	%	5.75
	8151500	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.18	CHEMBL5052	Homo sapiens	Inhibition	%	1.18
	8151638	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.03	CHEMBL5052	Homo sapiens	Inhibition	%	0.03
	8151862	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.48	CHEMBL5052	Homo sapiens	Inhibition	%	-0.48
	8152016	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.13	CHEMBL5052	Homo sapiens	Inhibition	%	-0.13
	8152204	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-0.15	CHEMBL5052	Homo sapiens	Inhibition	%	-0.15
	8152428	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.12	CHEMBL5052	Homo sapiens	Inhibition	%	0.12
	8152586	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.28	CHEMBL5052	Homo sapiens	Inhibition	%	0.28
	8152924	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.83	CHEMBL5052	Homo sapiens	Inhibition	%	0.83
	8153063	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.68	CHEMBL5052	Homo sapiens	Inhibition	%	-0.68
	8153424	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	0.36	CHEMBL5052	Homo sapiens	Inhibition	%	0.36
	8153581	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.09	CHEMBL5052	Homo sapiens	Inhibition	%	-0.09
	8153805	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.74	CHEMBL5052	Homo sapiens	Inhibition	%	0.74
	8153938	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	66.66	CHEMBL5052	Homo sapiens	Inhibition	%	66.66
	8154259	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.39	CHEMBL5052	Homo sapiens	Inhibition	%	1.39
	8154385	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.67	CHEMBL5052	Homo sapiens	Inhibition	%	2.67
	8154609	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.36	CHEMBL5052	Homo sapiens	Inhibition	%	1.36
	8154768	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-3.2	CHEMBL5052	Homo sapiens	Inhibition	%	-3.2
	8155112	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.68	CHEMBL5052	Homo sapiens	Inhibition	%	0.68
	8155288	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.89	CHEMBL5052	Homo sapiens	Inhibition	%	-0.89
	8155673	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.17	CHEMBL5052	Homo sapiens	Inhibition	%	0.17
	8155851	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.16	CHEMBL5052	Homo sapiens	Inhibition	%	2.16
	8156213	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-1.84	CHEMBL5052	Homo sapiens	Inhibition	%	-1.84
	8156425	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.15	CHEMBL5052	Homo sapiens	Inhibition	%	1.15
	8156575	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-0.03	CHEMBL5052	Homo sapiens	Inhibition	%	-0.03
	8156799	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.01	CHEMBL5052	Homo sapiens	Inhibition	%	0.01
	8156942	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.14	CHEMBL5052	Homo sapiens	Inhibition	%	1.14
	8157286	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	37.38	CHEMBL5052	Homo sapiens	Inhibition	%	37.38
	8157427	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-1.16	CHEMBL5052	Homo sapiens	Inhibition	%	-1.16
	8157651	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-0.4	CHEMBL5052	Homo sapiens	Inhibition	%	-0.4
	8157781	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	0.99	CHEMBL5052	Homo sapiens	Inhibition	%	0.99
	8158166	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.45	CHEMBL5052	Homo sapiens	Inhibition	%	2.45
	8158416	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	23.1	CHEMBL5052	Homo sapiens	Inhibition	%	23.1
	8158574	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.5	CHEMBL5052	Homo sapiens	Inhibition	%	2.5
	8158967	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.47	CHEMBL5052	Homo sapiens	Inhibition	%	-0.47
	8159102	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.34	CHEMBL5052	Homo sapiens	Inhibition	%	0.34
	8159326	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.26	CHEMBL5052	Homo sapiens	Inhibition	%	0.26
	8159446	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.15	CHEMBL5052	Homo sapiens	Inhibition	%	2.15
	8159801	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	1.55	CHEMBL5052	Homo sapiens	Inhibition	%	1.55
	8159942	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.63	CHEMBL5052	Homo sapiens	Inhibition	%	4.63
	8160303	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.37	CHEMBL5052	Homo sapiens	Inhibition	%	0.37
	8160453	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.88	CHEMBL5052	Homo sapiens	Inhibition	%	0.88
	8160747	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.58	CHEMBL5052	Homo sapiens	Inhibition	%	1.58
	8161121	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.6	CHEMBL5052	Homo sapiens	Inhibition	%	0.6
	8161264	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	1.21	CHEMBL5052	Homo sapiens	Inhibition	%	1.21
	8161488	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	1.8	CHEMBL5052	Homo sapiens	Inhibition	%	1.8
	8161613	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.4	CHEMBL5052	Homo sapiens	Inhibition	%	1.4
	8161975	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	-0.58	CHEMBL5052	Homo sapiens	Inhibition	%	-0.58
	8162105	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	6.81	CHEMBL5052	Homo sapiens	Inhibition	%	6.81
	8162489	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.84	CHEMBL5052	Homo sapiens	Inhibition	%	2.84
	8162742	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	67.22	CHEMBL5052	Homo sapiens	Inhibition	%	67.22
	8162890	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	5.03	CHEMBL5052	Homo sapiens	Inhibition	%	5.03
	8163114	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	15.36	CHEMBL5052	Homo sapiens	Inhibition	%	15.36
	8163283	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.93	CHEMBL5052	Homo sapiens	Inhibition	%	0.93
	8163641	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	-0.61	CHEMBL5052	Homo sapiens	Inhibition	%	-0.61
	8163764	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	9.93	CHEMBL5052	Homo sapiens	Inhibition	%	9.93
	8164122	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	13.01	CHEMBL5052	Homo sapiens	Inhibition	%	13.01
	8164262	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.89	CHEMBL5052	Homo sapiens	Inhibition	%	0.89
	8164486	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.72	CHEMBL5052	Homo sapiens	Inhibition	%	1.72
	8164641	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	-1.54	CHEMBL5052	Homo sapiens	Inhibition	%	-1.54
	8164785	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.56	CHEMBL5052	Homo sapiens	Inhibition	%	0.56
	8165009	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-0.12	CHEMBL5052	Homo sapiens	Inhibition	%	-0.12
	8165079	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.2	CHEMBL5052	Homo sapiens	Inhibition	%	1.2
	8165303	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.41	CHEMBL5052	Homo sapiens	Inhibition	%	2.41
	8165444	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-0.85	CHEMBL5052	Homo sapiens	Inhibition	%	-0.85
	8165811	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.11	CHEMBL5052	Homo sapiens	Inhibition	%	0.11
	8165937	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.99	CHEMBL5052	Homo sapiens	Inhibition	%	3.99
	8166299	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.02	CHEMBL5052	Homo sapiens	Inhibition	%	2.02
	8166429	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	-0.32	CHEMBL5052	Homo sapiens	Inhibition	%	-0.32
	8166653	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	0.92	CHEMBL5052	Homo sapiens	Inhibition	%	0.92
	8166754	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.78	CHEMBL5052	Homo sapiens	Inhibition	%	1.78
	8167066	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	17.77	CHEMBL5052	Homo sapiens	Inhibition	%	17.77
	8167431	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.54	CHEMBL5052	Homo sapiens	Inhibition	%	4.54
	8167595	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.57	CHEMBL5052	Homo sapiens	Inhibition	%	1.57
	8167952	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.2	CHEMBL5052	Homo sapiens	Inhibition	%	1.2
	8168076	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	5.57	CHEMBL5052	Homo sapiens	Inhibition	%	5.57
	8168300	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	29.95	CHEMBL5052	Homo sapiens	Inhibition	%	29.95
	8168441	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	0.29	CHEMBL5052	Homo sapiens	Inhibition	%	0.29
	8168801	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.03	CHEMBL5052	Homo sapiens	Inhibition	%	0.03
	8168965	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	1.01	CHEMBL5052	Homo sapiens	Inhibition	%	1.01
	8169331	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.45	CHEMBL5052	Homo sapiens	Inhibition	%	1.45
	8169635	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.24	CHEMBL5052	Homo sapiens	Inhibition	%	1.24
	8169769	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.79	CHEMBL5052	Homo sapiens	Inhibition	%	0.79
	8170138	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.52	CHEMBL5052	Homo sapiens	Inhibition	%	1.52
	8170263	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.33	CHEMBL5052	Homo sapiens	Inhibition	%	1.33
	8170487	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.51	CHEMBL5052	Homo sapiens	Inhibition	%	2.51
	8170627	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.36	CHEMBL5052	Homo sapiens	Inhibition	%	2.36
	8170986	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-1.18	CHEMBL5052	Homo sapiens	Inhibition	%	-1.18
	8171183	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.88	CHEMBL5052	Homo sapiens	Inhibition	%	1.88
	8171400	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	58.98	CHEMBL5052	Homo sapiens	Inhibition	%	58.98
	8171765	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	14.86	CHEMBL5052	Homo sapiens	Inhibition	%	14.86
	8171918	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.2	CHEMBL5052	Homo sapiens	Inhibition	%	1.2
	8172142	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.38	CHEMBL5052	Homo sapiens	Inhibition	%	0.38
	8172274	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	-0.63	CHEMBL5052	Homo sapiens	Inhibition	%	-0.63
	8172626	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.02	CHEMBL5052	Homo sapiens	Inhibition	%	1.02
	8172768	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.28	CHEMBL5052	Homo sapiens	Inhibition	%	2.28
	8173128	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.23	CHEMBL5052	Homo sapiens	Inhibition	%	2.23
	8173293	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	0.53	CHEMBL5052	Homo sapiens	Inhibition	%	0.53
	8173517	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	0.77	CHEMBL5052	Homo sapiens	Inhibition	%	0.77
	8173658	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	0.92	CHEMBL5052	Homo sapiens	Inhibition	%	0.92
	8173969	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.13	CHEMBL5052	Homo sapiens	Inhibition	%	2.13
	8174101	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-0.09	CHEMBL5052	Homo sapiens	Inhibition	%	-0.09
	8174325	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.48	CHEMBL5052	Homo sapiens	Inhibition	%	0.48
	8174473	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.52	CHEMBL5052	Homo sapiens	Inhibition	%	1.52
	8174819	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.07	CHEMBL5052	Homo sapiens	Inhibition	%	1.07
	8174962	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	21.11	CHEMBL5052	Homo sapiens	Inhibition	%	21.11
	8175322	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-0.74	CHEMBL5052	Homo sapiens	Inhibition	%	-0.74
	8175578	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.08	CHEMBL5052	Homo sapiens	Inhibition	%	1.08
	8175741	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.01	CHEMBL5052	Homo sapiens	Inhibition	%	1.01
	8175965	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.81	CHEMBL5052	Homo sapiens	Inhibition	%	3.81
	8176118	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	59.76	CHEMBL5052	Homo sapiens	Inhibition	%	59.76
	8176491	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.12	CHEMBL5052	Homo sapiens	Inhibition	%	1.12
	8176623	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	-1.04	CHEMBL5052	Homo sapiens	Inhibition	%	-1.04
	8176977	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.11	CHEMBL5052	Homo sapiens	Inhibition	%	2.11
	8177119	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	0.47	CHEMBL5052	Homo sapiens	Inhibition	%	0.47
	8177343	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	0.57	CHEMBL5052	Homo sapiens	Inhibition	%	0.57
	8177481	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	-0.86	CHEMBL5052	Homo sapiens	Inhibition	%	-0.86
	8177869	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	0.89	CHEMBL5052	Homo sapiens	Inhibition	%	0.89
	8178009	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.01	CHEMBL5052	Homo sapiens	Inhibition	%	1.01
	8178321	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.58	CHEMBL5052	Homo sapiens	Inhibition	%	0.58
	8178672	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	-0.45	CHEMBL5052	Homo sapiens	Inhibition	%	-0.45
	8178821	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.09	CHEMBL5052	Homo sapiens	Inhibition	%	1.09
	8179168	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.37	CHEMBL5052	Homo sapiens	Inhibition	%	0.37
	8179312	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	-0.38	CHEMBL5052	Homo sapiens	Inhibition	%	-0.38
	8179536	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.29	CHEMBL5052	Homo sapiens	Inhibition	%	2.29
	8179673	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-0.36	CHEMBL5052	Homo sapiens	Inhibition	%	-0.36
	8179930	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-0.23	CHEMBL5052	Homo sapiens	Inhibition	%	-0.23
	8180308	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.61	CHEMBL5052	Homo sapiens	Inhibition	%	0.61
	8180464	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	83.53	CHEMBL5052	Homo sapiens	Inhibition	%	83.53
	8180836	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.85	CHEMBL5052	Homo sapiens	Inhibition	%	2.85
	8180969	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	-0.33	CHEMBL5052	Homo sapiens	Inhibition	%	-0.33
	8181193	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.42	CHEMBL5052	Homo sapiens	Inhibition	%	1.42
	8181324	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.47	CHEMBL5052	Homo sapiens	Inhibition	%	0.47
	8181688	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.91	CHEMBL5052	Homo sapiens	Inhibition	%	0.91
	8181827	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.96	CHEMBL5052	Homo sapiens	Inhibition	%	2.96
	8182051	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	-0.01	CHEMBL5052	Homo sapiens	Inhibition	%	-0.01
	8182214	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	0.94	CHEMBL5052	Homo sapiens	Inhibition	%	0.94
	8182354	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.35	CHEMBL5052	Homo sapiens	Inhibition	%	-0.35
	8182578	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.04	CHEMBL5052	Homo sapiens	Inhibition	%	1.04
	8182670	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.77	CHEMBL5052	Homo sapiens	Inhibition	%	2.77
	8183016	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	0.66	CHEMBL5052	Homo sapiens	Inhibition	%	0.66
	8183165	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.48	CHEMBL5052	Homo sapiens	Inhibition	%	-0.48
	8183389	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	0.59	CHEMBL5052	Homo sapiens	Inhibition	%	0.59
	8183518	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.18	CHEMBL5052	Homo sapiens	Inhibition	%	6.18
	8183884	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.03	CHEMBL5052	Homo sapiens	Inhibition	%	0.03
	8184020	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.64	CHEMBL5052	Homo sapiens	Inhibition	%	0.64
	8184244	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.04	CHEMBL5052	Homo sapiens	Inhibition	%	0.04
	8184286	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.78	CHEMBL5052	Homo sapiens	Inhibition	%	0.78
	8184510	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.01	CHEMBL5052	Homo sapiens	Inhibition	%	-0.01
	8184657	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.75	CHEMBL5052	Homo sapiens	Inhibition	%	0.75
	8184814	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-0.17	CHEMBL5052	Homo sapiens	Inhibition	%	-0.17
	8185038	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.27	CHEMBL5052	Homo sapiens	Inhibition	%	1.27
	8185187	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.09	CHEMBL5052	Homo sapiens	Inhibition	%	0.09
	8185542	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	0.55	CHEMBL5052	Homo sapiens	Inhibition	%	0.55
	8185673	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	3.4	CHEMBL5052	Homo sapiens	Inhibition	%	3.4
	8185897	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	-0.06	CHEMBL5052	Homo sapiens	Inhibition	%	-0.06
	8186036	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.02	CHEMBL5052	Homo sapiens	Inhibition	%	0.02
	8186401	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	-0.11	CHEMBL5052	Homo sapiens	Inhibition	%	-0.11
	8186565	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.1	CHEMBL5052	Homo sapiens	Inhibition	%	1.1
	8186928	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.09	CHEMBL5052	Homo sapiens	Inhibition	%	1.09
	8187026	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.39	CHEMBL5052	Homo sapiens	Inhibition	%	1.39
	8187250	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.02	CHEMBL5052	Homo sapiens	Inhibition	%	1.02
	8187374	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	0.42	CHEMBL5052	Homo sapiens	Inhibition	%	0.42
	8187746	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.83	CHEMBL5052	Homo sapiens	Inhibition	%	0.83
	8187875	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.64	CHEMBL5052	Homo sapiens	Inhibition	%	4.64
	8188099	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.16	CHEMBL5052	Homo sapiens	Inhibition	%	2.16
	8188242	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.67	CHEMBL5052	Homo sapiens	Inhibition	%	0.67
	8188601	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.16	CHEMBL5052	Homo sapiens	Inhibition	%	0.16
	8188875	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.15	CHEMBL5052	Homo sapiens	Inhibition	%	-0.15
	8189023	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.84	CHEMBL5052	Homo sapiens	Inhibition	%	0.84
	8189403	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	0.57	CHEMBL5052	Homo sapiens	Inhibition	%	0.57
	8189552	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.09	CHEMBL5052	Homo sapiens	Inhibition	%	1.09
	8189908	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.44	CHEMBL5052	Homo sapiens	Inhibition	%	1.44
	8190264	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	-0.72	CHEMBL5052	Homo sapiens	Inhibition	%	-0.72
	8190404	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.07	CHEMBL5052	Homo sapiens	Inhibition	%	1.07
	8190765	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-1.48	CHEMBL5052	Homo sapiens	Inhibition	%	-1.48
	8190929	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	0.12	CHEMBL5052	Homo sapiens	Inhibition	%	0.12
	8191153	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	-0.3	CHEMBL5052	Homo sapiens	Inhibition	%	-0.3
	8191291	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.25	CHEMBL5052	Homo sapiens	Inhibition	%	2.25
	8191611	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-0.07	CHEMBL5052	Homo sapiens	Inhibition	%	-0.07
	8191733	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	-0.61	CHEMBL5052	Homo sapiens	Inhibition	%	-0.61
	8191957	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	-0.96	CHEMBL5052	Homo sapiens	Inhibition	%	-0.96
	8192106	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.46	CHEMBL5052	Homo sapiens	Inhibition	%	1.46
	8192459	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.99	CHEMBL5052	Homo sapiens	Inhibition	%	2.99
	8192603	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	-0.34	CHEMBL5052	Homo sapiens	Inhibition	%	-0.34
	8192963	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.09	CHEMBL5052	Homo sapiens	Inhibition	%	0.09
	8193235	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-1.54	CHEMBL5052	Homo sapiens	Inhibition	%	-1.54
	8193380	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.35	CHEMBL5052	Homo sapiens	Inhibition	%	0.35
	8193604	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.86	CHEMBL5052	Homo sapiens	Inhibition	%	0.86
	8193761	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.14	CHEMBL5052	Homo sapiens	Inhibition	%	2.14
	8193910	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.1	CHEMBL5052	Homo sapiens	Inhibition	%	-0.1
	8194134	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.55	CHEMBL5052	Homo sapiens	Inhibition	%	2.55
	8194265	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.59	CHEMBL5052	Homo sapiens	Inhibition	%	1.59
	8194620	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.69	CHEMBL5052	Homo sapiens	Inhibition	%	0.69
	8194763	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.4	CHEMBL5052	Homo sapiens	Inhibition	%	2.4
	8194987	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	0.33	CHEMBL5052	Homo sapiens	Inhibition	%	0.33
	8195120	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	0.28	CHEMBL5052	Homo sapiens	Inhibition	%	0.28
	8195508	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.6	CHEMBL5052	Homo sapiens	Inhibition	%	1.6
	8195647	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.91	CHEMBL5052	Homo sapiens	Inhibition	%	0.91
	8195969	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.54	CHEMBL5052	Homo sapiens	Inhibition	%	4.54
	8196310	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	-0.17	CHEMBL5052	Homo sapiens	Inhibition	%	-0.17
	8196460	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.04	CHEMBL5052	Homo sapiens	Inhibition	%	1.04
	8196812	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.67	CHEMBL5052	Homo sapiens	Inhibition	%	1.67
	8196953	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.83	CHEMBL5052	Homo sapiens	Inhibition	%	0.83
	8197177	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-1.66	CHEMBL5052	Homo sapiens	Inhibition	%	-1.66
	8197314	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.13	CHEMBL5052	Homo sapiens	Inhibition	%	0.13
	8197589	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-2.26	CHEMBL5052	Homo sapiens	Inhibition	%	-2.26
	8197953	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.67	CHEMBL5052	Homo sapiens	Inhibition	%	1.67
	8198110	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.28	CHEMBL5052	Homo sapiens	Inhibition	%	1.28
	8198472	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-1.2	CHEMBL5052	Homo sapiens	Inhibition	%	-1.2
	8198602	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	0.25	CHEMBL5052	Homo sapiens	Inhibition	%	0.25
	8198826	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	0.3	CHEMBL5052	Homo sapiens	Inhibition	%	0.3
	8198957	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.86	CHEMBL5052	Homo sapiens	Inhibition	%	1.86
	8199329	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	0.93	CHEMBL5052	Homo sapiens	Inhibition	%	0.93
	8199463	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	-0.25	CHEMBL5052	Homo sapiens	Inhibition	%	-0.25
	8199850	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.45	CHEMBL5052	Homo sapiens	Inhibition	%	1.45
	8199988	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.33	CHEMBL5052	Homo sapiens	Inhibition	%	1.33
	8200212	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.37	CHEMBL5052	Homo sapiens	Inhibition	%	1.37
	8200316	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.76	CHEMBL5052	Homo sapiens	Inhibition	%	0.76
	8200655	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	0.6	CHEMBL5052	Homo sapiens	Inhibition	%	0.6
	8200805	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.94	CHEMBL5052	Homo sapiens	Inhibition	%	1.94
	8201029	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.92	CHEMBL5052	Homo sapiens	Inhibition	%	0.92
	8201159	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.38	CHEMBL5052	Homo sapiens	Inhibition	%	1.38
	8201518	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-2.27	CHEMBL5052	Homo sapiens	Inhibition	%	-2.27
	8201651	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.22	CHEMBL5052	Homo sapiens	Inhibition	%	0.22
	8201875	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.15	CHEMBL5052	Homo sapiens	Inhibition	%	1.15
	8201930	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.15	CHEMBL5052	Homo sapiens	Inhibition	%	-0.15
	8202294	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.42	CHEMBL5052	Homo sapiens	Inhibition	%	0.42
	8202461	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.22	CHEMBL5052	Homo sapiens	Inhibition	%	3.22
	8202685	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.34	CHEMBL5052	Homo sapiens	Inhibition	%	4.34
	8202810	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-2.11	CHEMBL5052	Homo sapiens	Inhibition	%	-2.11
	8203164	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.08	CHEMBL5052	Homo sapiens	Inhibition	%	2.08
	8203295	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.8	CHEMBL5052	Homo sapiens	Inhibition	%	0.8
	8203665	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.55	CHEMBL5052	Homo sapiens	Inhibition	%	0.55
	8203799	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.29	CHEMBL5052	Homo sapiens	Inhibition	%	0.29
	8204023	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-0.39	CHEMBL5052	Homo sapiens	Inhibition	%	-0.39
	8204189	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.65	CHEMBL5052	Homo sapiens	Inhibition	%	2.65
	8204550	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.2	CHEMBL5052	Homo sapiens	Inhibition	%	0.2
	8204655	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.28	CHEMBL5052	Homo sapiens	Inhibition	%	1.28
	8204879	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.66	CHEMBL5052	Homo sapiens	Inhibition	%	0.66
	8204994	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	1.83	CHEMBL5052	Homo sapiens	Inhibition	%	1.83
	8205367	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.61	CHEMBL5052	Homo sapiens	Inhibition	%	0.61
	8205503	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.28	CHEMBL5052	Homo sapiens	Inhibition	%	1.28
	8205866	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-0.56	CHEMBL5052	Homo sapiens	Inhibition	%	-0.56
	8206222	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.24	CHEMBL5052	Homo sapiens	Inhibition	%	0.24
	8206274	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.67	CHEMBL5052	Homo sapiens	Inhibition	%	0.67
	8206498	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.69	CHEMBL5052	Homo sapiens	Inhibition	%	0.69
	8206641	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.83	CHEMBL5052	Homo sapiens	Inhibition	%	0.83
	8207045	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	22.64	CHEMBL5052	Homo sapiens	Inhibition	%	22.64
	8207171	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-0.33	CHEMBL5052	Homo sapiens	Inhibition	%	-0.33
	8207525	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	1.77	CHEMBL5052	Homo sapiens	Inhibition	%	1.77
	8207657	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.18	CHEMBL5052	Homo sapiens	Inhibition	%	0.18
	8207881	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.07	CHEMBL5052	Homo sapiens	Inhibition	%	1.07
	8208026	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.84	CHEMBL5052	Homo sapiens	Inhibition	%	3.84
	8208382	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	0.6	CHEMBL5052	Homo sapiens	Inhibition	%	0.6
	8208548	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	5.85	CHEMBL5052	Homo sapiens	Inhibition	%	5.85
	8208905	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.62	CHEMBL5052	Homo sapiens	Inhibition	%	7.62
	8209234	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.36	CHEMBL5052	Homo sapiens	Inhibition	%	1.36
	8209350	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-1.45	CHEMBL5052	Homo sapiens	Inhibition	%	-1.45
	8209574	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.91	CHEMBL5052	Homo sapiens	Inhibition	%	0.91
	8209724	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.24	CHEMBL5052	Homo sapiens	Inhibition	%	0.24
	8209860	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.92	CHEMBL5052	Homo sapiens	Inhibition	%	2.92
	8210084	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	0.35	CHEMBL5052	Homo sapiens	Inhibition	%	0.35
	8210225	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.45	CHEMBL5052	Homo sapiens	Inhibition	%	0.45
	8210585	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.47	CHEMBL5052	Homo sapiens	Inhibition	%	0.47
	8210844	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-0.22	CHEMBL5052	Homo sapiens	Inhibition	%	-0.22
	8210988	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-0.49	CHEMBL5052	Homo sapiens	Inhibition	%	-0.49
	8211212	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-0.87	CHEMBL5052	Homo sapiens	Inhibition	%	-0.87
	8211382	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.19	CHEMBL5052	Homo sapiens	Inhibition	%	1.19
	8211505	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	0.87	CHEMBL5052	Homo sapiens	Inhibition	%	0.87
	8211729	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-0.21	CHEMBL5052	Homo sapiens	Inhibition	%	-0.21
	8211858	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	15.5	CHEMBL5052	Homo sapiens	Inhibition	%	15.5
	8212214	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	0.42	CHEMBL5052	Homo sapiens	Inhibition	%	0.42
	8212355	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.84	CHEMBL5052	Homo sapiens	Inhibition	%	0.84
	8212579	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.66	CHEMBL5052	Homo sapiens	Inhibition	%	5.66
	8212712	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-0.19	CHEMBL5052	Homo sapiens	Inhibition	%	-0.19
	8212882	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	37.85	CHEMBL5052	Homo sapiens	Inhibition	%	37.85
	8213106	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.44	CHEMBL5052	Homo sapiens	Inhibition	%	0.44
	8213235	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	41.04	CHEMBL5052	Homo sapiens	Inhibition	%	41.04
	8213563	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.31	CHEMBL5052	Homo sapiens	Inhibition	%	0.31
	8213900	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.46	CHEMBL5052	Homo sapiens	Inhibition	%	0.46
	8214047	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.84	CHEMBL5052	Homo sapiens	Inhibition	%	1.84
	8214408	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	1.02	CHEMBL5052	Homo sapiens	Inhibition	%	1.02
	8214542	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.24	CHEMBL5052	Homo sapiens	Inhibition	%	-0.24
	8214766	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.07	CHEMBL5052	Homo sapiens	Inhibition	%	-0.07
	8214918	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.67	CHEMBL5052	Homo sapiens	Inhibition	%	7.67
	8215169	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.49	CHEMBL5052	Homo sapiens	Inhibition	%	0.49
	8215546	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.16	CHEMBL5052	Homo sapiens	Inhibition	%	1.16
	8215710	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.68	CHEMBL5052	Homo sapiens	Inhibition	%	1.68
	8216053	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-1.04	CHEMBL5052	Homo sapiens	Inhibition	%	-1.04
	8216172	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.62	CHEMBL5052	Homo sapiens	Inhibition	%	0.62
	8216396	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.16	CHEMBL5052	Homo sapiens	Inhibition	%	3.16
	8216532	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	1.68	CHEMBL5052	Homo sapiens	Inhibition	%	1.68
	8216894	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	9.27	CHEMBL5052	Homo sapiens	Inhibition	%	9.27
	8217028	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-0.8	CHEMBL5052	Homo sapiens	Inhibition	%	-0.8
	8217426	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.62	CHEMBL5052	Homo sapiens	Inhibition	%	3.62
	8217557	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	1.99	CHEMBL5052	Homo sapiens	Inhibition	%	1.99
	8217882	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.42	CHEMBL5052	Homo sapiens	Inhibition	%	-0.42
	8218221	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.41	CHEMBL5052	Homo sapiens	Inhibition	%	0.41
	8218348	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.49	CHEMBL5052	Homo sapiens	Inhibition	%	2.49
	8218572	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	8.24	CHEMBL5052	Homo sapiens	Inhibition	%	8.24
	8218715	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.63	CHEMBL5052	Homo sapiens	Inhibition	%	0.63
	8219070	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	-0.31	CHEMBL5052	Homo sapiens	Inhibition	%	-0.31
	8219230	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.68	CHEMBL5052	Homo sapiens	Inhibition	%	5.68
	8219480	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.1	CHEMBL5052	Homo sapiens	Inhibition	%	1.1
	8219865	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.93	CHEMBL5052	Homo sapiens	Inhibition	%	1.93
	8220034	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.32	CHEMBL5052	Homo sapiens	Inhibition	%	0.32
	8220387	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.19	CHEMBL5052	Homo sapiens	Inhibition	%	0.19
	8220725	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	23.84	CHEMBL5052	Homo sapiens	Inhibition	%	23.84
	8220863	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	1.65	CHEMBL5052	Homo sapiens	Inhibition	%	1.65
	8221223	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	42.68	CHEMBL5052	Homo sapiens	Inhibition	%	42.68
	8221356	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-1.28	CHEMBL5052	Homo sapiens	Inhibition	%	-1.28
	8221580	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	0.34	CHEMBL5052	Homo sapiens	Inhibition	%	0.34
	8221745	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.07	CHEMBL5052	Homo sapiens	Inhibition	%	1.07
	8221876	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.7	CHEMBL5052	Homo sapiens	Inhibition	%	4.7
	8222100	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	-0.16	CHEMBL5052	Homo sapiens	Inhibition	%	-0.16
	8222198	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-1.42	CHEMBL5052	Homo sapiens	Inhibition	%	-1.42
	8222556	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	0.24	CHEMBL5052	Homo sapiens	Inhibition	%	0.24
	8222898	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.5	CHEMBL5052	Homo sapiens	Inhibition	%	5.5
	8223042	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	1.86	CHEMBL5052	Homo sapiens	Inhibition	%	1.86
	8223395	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	-0.22	CHEMBL5052	Homo sapiens	Inhibition	%	-0.22
	8223556	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.11	CHEMBL5052	Homo sapiens	Inhibition	%	3.11
	8223780	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.93	CHEMBL5052	Homo sapiens	Inhibition	%	3.93
	8223806	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.15	CHEMBL5052	Homo sapiens	Inhibition	%	2.15
	8224030	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.98	CHEMBL5052	Homo sapiens	Inhibition	%	1.98
	8224192	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.8	CHEMBL5052	Homo sapiens	Inhibition	%	1.8
	8224362	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.76	CHEMBL5052	Homo sapiens	Inhibition	%	1.76
	8224586	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.23	CHEMBL5052	Homo sapiens	Inhibition	%	-0.23
	8224721	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-1.24	CHEMBL5052	Homo sapiens	Inhibition	%	-1.24
	8225059	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	65.51	CHEMBL5052	Homo sapiens	Inhibition	%	65.51
	8225193	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	0.64	CHEMBL5052	Homo sapiens	Inhibition	%	0.64
	8225417	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.33	CHEMBL5052	Homo sapiens	Inhibition	%	1.33
	8225555	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.65	CHEMBL5052	Homo sapiens	Inhibition	%	1.65
	8225914	CHEMBL1961886	GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.43	CHEMBL5052	Homo sapiens	Inhibition	%	0.43
	8226072	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.43	CHEMBL5052	Homo sapiens	Inhibition	%	3.43
	8226421	CHEMBL1961887	GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.38	CHEMBL5052	Homo sapiens	Inhibition	%	2.38
	10839410	CHEMBL2015072	Inhibition of MRCKb at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	27.0	CHEMBL5052	Homo sapiens	INH	%	27.0
	12046367	CHEMBL2157294	Inhibition of MRCKbeta at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-3.6	CHEMBL5052	Homo sapiens	INH	%	-3.6
	12172335	CHEMBL2215450	Inhibition of MRCKB assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	59.0	CHEMBL5052	Homo sapiens	Activity	%	59.0
	12237853	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	115.0	CHEMBL5052	Homo sapiens	Residual Activity	%	115.0
	12237854	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	81.0	CHEMBL5052	Homo sapiens	Residual Activity	%	81.0
	12237855	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	86.0	CHEMBL5052	Homo sapiens	Residual Activity	%	86.0
	12237856	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12237857	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	86.0	CHEMBL5052	Homo sapiens	Residual Activity	%	86.0
	12237858	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12237859	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12237860	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	102.0	CHEMBL5052	Homo sapiens	Residual Activity	%	102.0
	12237861	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	105.0	CHEMBL5052	Homo sapiens	Residual Activity	%	105.0
	12237862	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12237863	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12240463	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12240464	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12240465	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	99.0	CHEMBL5052	Homo sapiens	Residual Activity	%	99.0
	12240466	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	84.0	CHEMBL5052	Homo sapiens	Residual Activity	%	84.0
	12240467	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12240468	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12240469	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	90.0	CHEMBL5052	Homo sapiens	Residual Activity	%	90.0
	12240470	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12240471	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	78.0	CHEMBL5052	Homo sapiens	Residual Activity	%	78.0
	12240472	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12240473	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	79.0	CHEMBL5052	Homo sapiens	Residual Activity	%	79.0
	12240474	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12240475	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12240476	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	103.0	CHEMBL5052	Homo sapiens	Residual Activity	%	103.0
	12240477	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	84.0	CHEMBL5052	Homo sapiens	Residual Activity	%	84.0
	12240478	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	77.0	CHEMBL5052	Homo sapiens	Residual Activity	%	77.0
	12240479	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12240480	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12240481	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12240482	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	96.0	CHEMBL5052	Homo sapiens	Residual Activity	%	96.0
	12240483	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12240484	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	96.0	CHEMBL5052	Homo sapiens	Residual Activity	%	96.0
	12240485	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12240486	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12240487	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	82.0	CHEMBL5052	Homo sapiens	Residual Activity	%	82.0
	12240488	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	84.0	CHEMBL5052	Homo sapiens	Residual Activity	%	84.0
	12240489	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12240490	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12240491	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12240492	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	108.0	CHEMBL5052	Homo sapiens	Residual Activity	%	108.0
	12240493	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	100.0	CHEMBL5052	Homo sapiens	Residual Activity	%	100.0
	12240494	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	74.0	CHEMBL5052	Homo sapiens	Residual Activity	%	74.0
	12240495	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	66.0	CHEMBL5052	Homo sapiens	Residual Activity	%	66.0
	12240496	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	84.0	CHEMBL5052	Homo sapiens	Residual Activity	%	84.0
	12240497	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	94.0	CHEMBL5052	Homo sapiens	Residual Activity	%	94.0
	12240498	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12240499	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	99.0	CHEMBL5052	Homo sapiens	Residual Activity	%	99.0
	12240500	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	116.0	CHEMBL5052	Homo sapiens	Residual Activity	%	116.0
	12240501	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12240502	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	80.0	CHEMBL5052	Homo sapiens	Residual Activity	%	80.0
	12240503	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	90.0	CHEMBL5052	Homo sapiens	Residual Activity	%	90.0
	12240504	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	75.0	CHEMBL5052	Homo sapiens	Residual Activity	%	75.0
	12240505	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12240506	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12240507	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	104.0	CHEMBL5052	Homo sapiens	Residual Activity	%	104.0
	12240508	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	112.0	CHEMBL5052	Homo sapiens	Residual Activity	%	112.0
	12240509	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	94.0	CHEMBL5052	Homo sapiens	Residual Activity	%	94.0
	12240510	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12240511	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	94.0	CHEMBL5052	Homo sapiens	Residual Activity	%	94.0
	12240512	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	80.0	CHEMBL5052	Homo sapiens	Residual Activity	%	80.0
	12240513	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	85.0	CHEMBL5052	Homo sapiens	Residual Activity	%	85.0
	12240514	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	96.0	CHEMBL5052	Homo sapiens	Residual Activity	%	96.0
	12240515	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12240516	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	117.0	CHEMBL5052	Homo sapiens	Residual Activity	%	117.0
	12240517	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	106.0	CHEMBL5052	Homo sapiens	Residual Activity	%	106.0
	12240518	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	97.0	CHEMBL5052	Homo sapiens	Residual Activity	%	97.0
	12240519	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	93.0	CHEMBL5052	Homo sapiens	Residual Activity	%	93.0
	12240520	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	93.0	CHEMBL5052	Homo sapiens	Residual Activity	%	93.0
	12240521	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	99.0	CHEMBL5052	Homo sapiens	Residual Activity	%	99.0
	12240522	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12240523	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	103.0	CHEMBL5052	Homo sapiens	Residual Activity	%	103.0
	12240524	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12240525	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12240526	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	106.0	CHEMBL5052	Homo sapiens	Residual Activity	%	106.0
	12240527	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	99.0	CHEMBL5052	Homo sapiens	Residual Activity	%	99.0
	12240528	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	106.0	CHEMBL5052	Homo sapiens	Residual Activity	%	106.0
	12240529	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	103.0	CHEMBL5052	Homo sapiens	Residual Activity	%	103.0
	12240530	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12240531	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL5052	Homo sapiens	Residual Activity	%	0.0
	12240532	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	105.0	CHEMBL5052	Homo sapiens	Residual Activity	%	105.0
	12240533	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	84.0	CHEMBL5052	Homo sapiens	Residual Activity	%	84.0
	12240534	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	85.0	CHEMBL5052	Homo sapiens	Residual Activity	%	85.0
	12240535	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12240536	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	97.0	CHEMBL5052	Homo sapiens	Residual Activity	%	97.0
	12240537	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	108.0	CHEMBL5052	Homo sapiens	Residual Activity	%	108.0
	12240538	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	104.0	CHEMBL5052	Homo sapiens	Residual Activity	%	104.0
	12240539	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	113.0	CHEMBL5052	Homo sapiens	Residual Activity	%	113.0
	12240540	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	93.0	CHEMBL5052	Homo sapiens	Residual Activity	%	93.0
	12240541	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	106.0	CHEMBL5052	Homo sapiens	Residual Activity	%	106.0
	12240542	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12240543	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	90.0	CHEMBL5052	Homo sapiens	Residual Activity	%	90.0
	12240544	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	96.0	CHEMBL5052	Homo sapiens	Residual Activity	%	96.0
	12240545	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	101.0	CHEMBL5052	Homo sapiens	Residual Activity	%	101.0
	12240546	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	99.0	CHEMBL5052	Homo sapiens	Residual Activity	%	99.0
	12240547	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	101.0	CHEMBL5052	Homo sapiens	Residual Activity	%	101.0
	12240548	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	97.0	CHEMBL5052	Homo sapiens	Residual Activity	%	97.0
	12240549	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12240550	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12240551	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12240552	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	82.0	CHEMBL5052	Homo sapiens	Residual Activity	%	82.0
	12240553	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	33.0	CHEMBL5052	Homo sapiens	Residual Activity	%	33.0
	12240554	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	102.0	CHEMBL5052	Homo sapiens	Residual Activity	%	102.0
	12240555	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	103.0	CHEMBL5052	Homo sapiens	Residual Activity	%	103.0
	12240556	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	48.0	CHEMBL5052	Homo sapiens	Residual Activity	%	48.0
	12240557	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12240558	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	79.0	CHEMBL5052	Homo sapiens	Residual Activity	%	79.0
	12240559	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	90.0	CHEMBL5052	Homo sapiens	Residual Activity	%	90.0
	12240560	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12240561	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	72.0	CHEMBL5052	Homo sapiens	Residual Activity	%	72.0
	12240562	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12240563	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	105.0	CHEMBL5052	Homo sapiens	Residual Activity	%	105.0
	12240564	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	9.0	CHEMBL5052	Homo sapiens	Residual Activity	%	9.0
	12240565	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12240566	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	94.0	CHEMBL5052	Homo sapiens	Residual Activity	%	94.0
	12240567	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	73.0	CHEMBL5052	Homo sapiens	Residual Activity	%	73.0
	12240568	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	80.0	CHEMBL5052	Homo sapiens	Residual Activity	%	80.0
	12240569	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12240570	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12240571	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	99.0	CHEMBL5052	Homo sapiens	Residual Activity	%	99.0
	12240572	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	101.0	CHEMBL5052	Homo sapiens	Residual Activity	%	101.0
	12240573	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	94.0	CHEMBL5052	Homo sapiens	Residual Activity	%	94.0
	12240574	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	85.0	CHEMBL5052	Homo sapiens	Residual Activity	%	85.0
	12240575	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12240576	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	85.0	CHEMBL5052	Homo sapiens	Residual Activity	%	85.0
	12240577	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12240578	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12240579	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	111.0	CHEMBL5052	Homo sapiens	Residual Activity	%	111.0
	12240580	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	103.0	CHEMBL5052	Homo sapiens	Residual Activity	%	103.0
	12240581	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	8.0	CHEMBL5052	Homo sapiens	Residual Activity	%	8.0
	12240582	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12240583	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	86.0	CHEMBL5052	Homo sapiens	Residual Activity	%	86.0
	12240584	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	90.0	CHEMBL5052	Homo sapiens	Residual Activity	%	90.0
	12240585	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	100.0	CHEMBL5052	Homo sapiens	Residual Activity	%	100.0
	12240586	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12240587	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	100.0	CHEMBL5052	Homo sapiens	Residual Activity	%	100.0
	12240588	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	86.0	CHEMBL5052	Homo sapiens	Residual Activity	%	86.0
	12240589	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	76.0	CHEMBL5052	Homo sapiens	Residual Activity	%	76.0
	12240590	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12240591	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12240592	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	94.0	CHEMBL5052	Homo sapiens	Residual Activity	%	94.0
	12240593	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	97.0	CHEMBL5052	Homo sapiens	Residual Activity	%	97.0
	12240594	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	93.0	CHEMBL5052	Homo sapiens	Residual Activity	%	93.0
	12240595	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	106.0	CHEMBL5052	Homo sapiens	Residual Activity	%	106.0
	12240596	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12240597	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	97.0	CHEMBL5052	Homo sapiens	Residual Activity	%	97.0
	12240598	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	96.0	CHEMBL5052	Homo sapiens	Residual Activity	%	96.0
	12240599	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	93.0	CHEMBL5052	Homo sapiens	Residual Activity	%	93.0
	12240600	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12240601	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	108.0	CHEMBL5052	Homo sapiens	Residual Activity	%	108.0
	12240602	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	110.0	CHEMBL5052	Homo sapiens	Residual Activity	%	110.0
	12240603	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	106.0	CHEMBL5052	Homo sapiens	Residual Activity	%	106.0
	12240604	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	101.0	CHEMBL5052	Homo sapiens	Residual Activity	%	101.0
	12240605	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	102.0	CHEMBL5052	Homo sapiens	Residual Activity	%	102.0
	12240606	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	100.0	CHEMBL5052	Homo sapiens	Residual Activity	%	100.0
	12240607	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	103.0	CHEMBL5052	Homo sapiens	Residual Activity	%	103.0
	12240608	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	105.0	CHEMBL5052	Homo sapiens	Residual Activity	%	105.0
	12240609	CHEMBL2219277	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	6.0	CHEMBL5052	Homo sapiens	Residual Activity	%	6.0
	12240610	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12240611	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	84.0	CHEMBL5052	Homo sapiens	Residual Activity	%	84.0
	12240612	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12240613	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	76.0	CHEMBL5052	Homo sapiens	Residual Activity	%	76.0
	12240614	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	84.0	CHEMBL5052	Homo sapiens	Residual Activity	%	84.0
	12240615	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12240616	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12240617	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	104.0	CHEMBL5052	Homo sapiens	Residual Activity	%	104.0
	12240618	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	100.0	CHEMBL5052	Homo sapiens	Residual Activity	%	100.0
	12240619	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12240620	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	79.0	CHEMBL5052	Homo sapiens	Residual Activity	%	79.0
	12240621	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12240622	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	77.0	CHEMBL5052	Homo sapiens	Residual Activity	%	77.0
	12240623	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	86.0	CHEMBL5052	Homo sapiens	Residual Activity	%	86.0
	12240624	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	94.0	CHEMBL5052	Homo sapiens	Residual Activity	%	94.0
	12240625	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12240626	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12240627	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	81.0	CHEMBL5052	Homo sapiens	Residual Activity	%	81.0
	12240628	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	74.0	CHEMBL5052	Homo sapiens	Residual Activity	%	74.0
	12240629	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	76.0	CHEMBL5052	Homo sapiens	Residual Activity	%	76.0
	12240630	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	79.0	CHEMBL5052	Homo sapiens	Residual Activity	%	79.0
	12240631	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	64.0	CHEMBL5052	Homo sapiens	Residual Activity	%	64.0
	12240632	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12240633	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	90.0	CHEMBL5052	Homo sapiens	Residual Activity	%	90.0
	12240634	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12240635	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	72.0	CHEMBL5052	Homo sapiens	Residual Activity	%	72.0
	12240636	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	82.0	CHEMBL5052	Homo sapiens	Residual Activity	%	82.0
	12240637	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	71.0	CHEMBL5052	Homo sapiens	Residual Activity	%	71.0
	12240638	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12240639	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	41.0	CHEMBL5052	Homo sapiens	Residual Activity	%	41.0
	12240640	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12240641	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	71.0	CHEMBL5052	Homo sapiens	Residual Activity	%	71.0
	12240642	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	82.0	CHEMBL5052	Homo sapiens	Residual Activity	%	82.0
	12240643	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	78.0	CHEMBL5052	Homo sapiens	Residual Activity	%	78.0
	12240644	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	80.0	CHEMBL5052	Homo sapiens	Residual Activity	%	80.0
	12240645	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	77.0	CHEMBL5052	Homo sapiens	Residual Activity	%	77.0
	12240646	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	100.0	CHEMBL5052	Homo sapiens	Residual Activity	%	100.0
	12240647	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	104.0	CHEMBL5052	Homo sapiens	Residual Activity	%	104.0
	12240648	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	86.0	CHEMBL5052	Homo sapiens	Residual Activity	%	86.0
	12240649	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	82.0	CHEMBL5052	Homo sapiens	Residual Activity	%	82.0
	12240650	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	99.0	CHEMBL5052	Homo sapiens	Residual Activity	%	99.0
	12240651	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12240652	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	64.0	CHEMBL5052	Homo sapiens	Residual Activity	%	64.0
	12240653	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	21.0	CHEMBL5052	Homo sapiens	Residual Activity	%	21.0
	12240654	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	67.0	CHEMBL5052	Homo sapiens	Residual Activity	%	67.0
	12240655	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	60.0	CHEMBL5052	Homo sapiens	Residual Activity	%	60.0
	12240656	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	78.0	CHEMBL5052	Homo sapiens	Residual Activity	%	78.0
	12240657	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12240658	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12240659	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	85.0	CHEMBL5052	Homo sapiens	Residual Activity	%	85.0
	12240660	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	41.0	CHEMBL5052	Homo sapiens	Residual Activity	%	41.0
	12240661	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	69.0	CHEMBL5052	Homo sapiens	Residual Activity	%	69.0
	12240662	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	49.0	CHEMBL5052	Homo sapiens	Residual Activity	%	49.0
	12240663	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	80.0	CHEMBL5052	Homo sapiens	Residual Activity	%	80.0
	12240664	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	82.0	CHEMBL5052	Homo sapiens	Residual Activity	%	82.0
	12240665	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12240666	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	90.0	CHEMBL5052	Homo sapiens	Residual Activity	%	90.0
	12240667	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	86.0	CHEMBL5052	Homo sapiens	Residual Activity	%	86.0
	12240668	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	115.0	CHEMBL5052	Homo sapiens	Residual Activity	%	115.0
	12240669	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	65.0	CHEMBL5052	Homo sapiens	Residual Activity	%	65.0
	12240670	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	67.0	CHEMBL5052	Homo sapiens	Residual Activity	%	67.0
	12240671	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	68.0	CHEMBL5052	Homo sapiens	Residual Activity	%	68.0
	12240672	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	84.0	CHEMBL5052	Homo sapiens	Residual Activity	%	84.0
	12240673	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	82.0	CHEMBL5052	Homo sapiens	Residual Activity	%	82.0
	12240674	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	108.0	CHEMBL5052	Homo sapiens	Residual Activity	%	108.0
	12240675	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	102.0	CHEMBL5052	Homo sapiens	Residual Activity	%	102.0
	12240676	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	77.0	CHEMBL5052	Homo sapiens	Residual Activity	%	77.0
	12240677	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	76.0	CHEMBL5052	Homo sapiens	Residual Activity	%	76.0
	12240678	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	53.0	CHEMBL5052	Homo sapiens	Residual Activity	%	53.0
	12240679	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	114.0	CHEMBL5052	Homo sapiens	Residual Activity	%	114.0
	12240680	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12240681	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12240682	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	40.0	CHEMBL5052	Homo sapiens	Residual Activity	%	40.0
	12240683	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12240684	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	109.0	CHEMBL5052	Homo sapiens	Residual Activity	%	109.0
	12240685	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	96.0	CHEMBL5052	Homo sapiens	Residual Activity	%	96.0
	12240686	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	85.0	CHEMBL5052	Homo sapiens	Residual Activity	%	85.0
	12240687	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12240688	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	79.0	CHEMBL5052	Homo sapiens	Residual Activity	%	79.0
	12240689	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL5052	Homo sapiens	Residual Activity	%	0.0
	12240690	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12240691	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	60.0	CHEMBL5052	Homo sapiens	Residual Activity	%	60.0
	12240692	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	85.0	CHEMBL5052	Homo sapiens	Residual Activity	%	85.0
	12240693	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	69.0	CHEMBL5052	Homo sapiens	Residual Activity	%	69.0
	12240694	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	104.0	CHEMBL5052	Homo sapiens	Residual Activity	%	104.0
	12240695	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL5052	Homo sapiens	Residual Activity	%	105.0
	12240696	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12243300	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	110.0	CHEMBL5052	Homo sapiens	Residual Activity	%	110.0
	12243301	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	93.0	CHEMBL5052	Homo sapiens	Residual Activity	%	93.0
	12243302	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	103.0	CHEMBL5052	Homo sapiens	Residual Activity	%	103.0
	12243303	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12243304	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	79.0	CHEMBL5052	Homo sapiens	Residual Activity	%	79.0
	12243305	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	99.0	CHEMBL5052	Homo sapiens	Residual Activity	%	99.0
	12243306	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	93.0	CHEMBL5052	Homo sapiens	Residual Activity	%	93.0
	12243307	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12243308	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12243309	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12243310	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12243311	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	86.0	CHEMBL5052	Homo sapiens	Residual Activity	%	86.0
	12243312	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12243313	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	79.0	CHEMBL5052	Homo sapiens	Residual Activity	%	79.0
	12243314	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	5.0	CHEMBL5052	Homo sapiens	Residual Activity	%	5.0
	12243315	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12243316	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	102.0	CHEMBL5052	Homo sapiens	Residual Activity	%	102.0
	12243317	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	57.0	CHEMBL5052	Homo sapiens	Residual Activity	%	57.0
	12243318	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12243319	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12243320	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	85.0	CHEMBL5052	Homo sapiens	Residual Activity	%	85.0
	12243321	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	84.0	CHEMBL5052	Homo sapiens	Residual Activity	%	84.0
	12243322	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	52.0	CHEMBL5052	Homo sapiens	Residual Activity	%	52.0
	12243323	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	89.0	CHEMBL5052	Homo sapiens	Residual Activity	%	89.0
	12243324	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	96.0	CHEMBL5052	Homo sapiens	Residual Activity	%	96.0
	12243325	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	6.0	CHEMBL5052	Homo sapiens	Residual Activity	%	6.0
	12243326	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12243327	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	106.0	CHEMBL5052	Homo sapiens	Residual Activity	%	106.0
	12243328	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	81.0	CHEMBL5052	Homo sapiens	Residual Activity	%	81.0
	12243329	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	50.0	CHEMBL5052	Homo sapiens	Residual Activity	%	50.0
	12243330	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	78.0	CHEMBL5052	Homo sapiens	Residual Activity	%	78.0
	12243331	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12243332	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12243333	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12243334	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	78.0	CHEMBL5052	Homo sapiens	Residual Activity	%	78.0
	12243335	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	82.0	CHEMBL5052	Homo sapiens	Residual Activity	%	82.0
	12243336	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	82.0	CHEMBL5052	Homo sapiens	Residual Activity	%	82.0
	12243337	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12243338	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	96.0	CHEMBL5052	Homo sapiens	Residual Activity	%	96.0
	12243339	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	88.0	CHEMBL5052	Homo sapiens	Residual Activity	%	88.0
	12243340	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	129.0	CHEMBL5052	Homo sapiens	Residual Activity	%	129.0
	12243341	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	93.0	CHEMBL5052	Homo sapiens	Residual Activity	%	93.0
	12243342	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	3.0	CHEMBL5052	Homo sapiens	Residual Activity	%	3.0
	12243343	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12243344	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	94.0	CHEMBL5052	Homo sapiens	Residual Activity	%	94.0
	12243345	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12243346	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	97.0	CHEMBL5052	Homo sapiens	Residual Activity	%	97.0
	12243347	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	84.0	CHEMBL5052	Homo sapiens	Residual Activity	%	84.0
	12243348	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	90.0	CHEMBL5052	Homo sapiens	Residual Activity	%	90.0
	12243349	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12243350	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	34.0	CHEMBL5052	Homo sapiens	Residual Activity	%	34.0
	12243351	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	87.0	CHEMBL5052	Homo sapiens	Residual Activity	%	87.0
	12243352	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	85.0	CHEMBL5052	Homo sapiens	Residual Activity	%	85.0
	12243353	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	98.0	CHEMBL5052	Homo sapiens	Residual Activity	%	98.0
	12243354	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	66.0	CHEMBL5052	Homo sapiens	Residual Activity	%	66.0
	12243355	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	93.0	CHEMBL5052	Homo sapiens	Residual Activity	%	93.0
	12243356	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	95.0	CHEMBL5052	Homo sapiens	Residual Activity	%	95.0
	12243357	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12243358	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	83.0	CHEMBL5052	Homo sapiens	Residual Activity	%	83.0
	12243359	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12243360	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	66.0	CHEMBL5052	Homo sapiens	Residual Activity	%	66.0
	12243361	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	106.0	CHEMBL5052	Homo sapiens	Residual Activity	%	106.0
	12243362	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	94.0	CHEMBL5052	Homo sapiens	Residual Activity	%	94.0
	12243363	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	93.0	CHEMBL5052	Homo sapiens	Residual Activity	%	93.0
	12243364	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	90.0	CHEMBL5052	Homo sapiens	Residual Activity	%	90.0
	12243365	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	91.0	CHEMBL5052	Homo sapiens	Residual Activity	%	91.0
	12243366	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	99.0	CHEMBL5052	Homo sapiens	Residual Activity	%	99.0
	12243367	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	99.0	CHEMBL5052	Homo sapiens	Residual Activity	%	99.0
	12243368	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	107.0	CHEMBL5052	Homo sapiens	Residual Activity	%	107.0
	12243369	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	92.0	CHEMBL5052	Homo sapiens	Residual Activity	%	92.0
	12243370	CHEMBL2219278	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	3.0	CHEMBL5052	Homo sapiens	Residual Activity	%	3.0
	12727726	CHEMBL2351160	Inhibition of MRCKbeta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	90.0	CHEMBL5052	Homo sapiens	Activity	%	90.0
	12729014	CHEMBL2350438	Inhibition of MRCKbeta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL5052	Homo sapiens	Activity	%	98.0
	12729898	CHEMBL2349803	Inhibition of MRCKB (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	101.0	CHEMBL5052	Homo sapiens	Activity	%	101.0
	12730157	CHEMBL2351160	Inhibition of MRCKbeta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	85.0	CHEMBL5052	Homo sapiens	Activity	%	85.0
	13375924	CHEMBL2405935	Inhibition of MRCKB (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	3.0	CHEMBL5052	Homo sapiens	INH	%	3.0
	13434750	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13434751	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13434752	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13434753	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13434754	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13434755	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13434756	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13434757	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13434758	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13434759	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13434760	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13436241	CHEMBL2424436	Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL5052	Homo sapiens	INH	%	35.0
	13439803	CHEMBL2426948	Competitive binding affinity to MRCKB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	13445636	CHEMBL2426948	Competitive binding affinity to MRCKB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	13451623	CHEMBL2426948	Competitive binding affinity to MRCKB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	13872090	CHEMBL3101276	Inhibition of human MRCKbeta assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	102.0	CHEMBL5052	Homo sapiens	Activity	%	102.0
	14582557	CHEMBL3241621	Inhibition of human MRCKbeta assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	104.5	CHEMBL5052	Homo sapiens	Activity	%	104.5
	14984392	CHEMBL3384983	Inhibition of MRCKB (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	44.0	CHEMBL5052	Homo sapiens	INH	%	44.0
	14984458	CHEMBL3381889	Inhibition of MRCKB (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	15.0	CHEMBL5052	Homo sapiens	INH	%	15.0
	15756904	CHEMBL3631452	Inhibition of MRCKbeta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	16.47	CHEMBL5052	Homo sapiens	INH	%	16.47
	15757819	CHEMBL3631452	Inhibition of MRCKbeta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	14.41	CHEMBL5052	Homo sapiens	INH	%	14.41
	15758798	CHEMBL3631452	Inhibition of MRCKbeta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	11.06	CHEMBL5052	Homo sapiens	INH	%	11.06
	16431914	CHEMBL3748007	Inhibition of human MRCKbeta using [KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5052	Homo sapiens	IC50	uM	10.0
	16451521	CHEMBL3760644	Inhibition of MRCKbeta (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-3.9	CHEMBL5052	Homo sapiens	INH	%	-3.9
	16495137	CHEMBL3777500	Inhibition of N-terminal His6-tagged recombinant human MRCKbeta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	4.0	CHEMBL5052	Homo sapiens	Activity	%	4.0
	16496056	CHEMBL3777500	Inhibition of N-terminal His6-tagged recombinant human MRCKbeta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	0.0	CHEMBL5052	Homo sapiens	Activity	%	0.0
	16508243	CHEMBL3777500	Inhibition of N-terminal His6-tagged recombinant human MRCKbeta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-8.0	CHEMBL5052	Homo sapiens	Activity	%	-8.0
	16614548	CHEMBL3817579	Inhibition of human MRCKbeta at 1 uM using [KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	2.0	CHEMBL5052	Homo sapiens	INH	%	2.0
Inactive	17887835	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887836	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887837	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887838	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887839	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887840	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887841	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887842	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887843	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887844	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887845	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887846	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887847	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887848	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887849	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887850	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887851	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887852	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887853	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887854	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887855	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887856	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887857	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887858	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887859	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887860	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887861	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887862	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887863	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887864	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887865	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887866	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887867	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887868	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887869	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887870	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887871	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887872	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887873	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887874	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887875	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887876	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887877	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887878	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887879	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887880	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887881	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887882	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887883	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887884	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887885	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887886	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887887	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887888	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887889	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887890	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887891	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887892	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887893	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887894	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887895	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887896	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887897	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887898	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887899	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887900	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887901	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Active	17887902	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	1726.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	1726.0
Inactive	17887903	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887904	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887905	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887906	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887907	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887908	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887909	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887910	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887911	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887912	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887913	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887914	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887915	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887916	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Active	17887917	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	116.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	116.0
Inactive	17887918	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887919	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887920	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887921	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887922	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887923	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887924	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887925	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887926	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887927	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887928	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887929	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887930	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887931	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887932	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887933	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887934	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887935	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887936	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887937	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887938	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887939	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887940	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887941	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887942	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Active	17887943	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	110.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	110.0
Inactive	17887944	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887945	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887946	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887947	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887948	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887949	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887950	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887951	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887952	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887953	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887954	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887955	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887956	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887957	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887958	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887959	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887960	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887961	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887962	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887963	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887964	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887965	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887966	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887967	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887968	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887969	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887970	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887971	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887972	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887973	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887974	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887975	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887976	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887977	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887978	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887979	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Active	17887980	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	50005.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	50005.0
Inactive	17887981	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887982	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887983	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17887984	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	46945.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	46945.0
Inactive	17887985	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887986	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887987	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887988	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887989	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887990	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887991	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887992	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887993	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887994	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887995	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Active	17887996	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	=	Kd	nM	16.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	16.0
Inactive	17887997	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887998	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887999	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888000	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888001	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888002	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888003	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888004	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888005	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888006	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888007	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888008	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888009	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888010	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888011	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888012	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888013	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888014	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888015	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888016	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Active	17888017	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	1020.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	1020.0
Inactive	17888018	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888019	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888020	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888021	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888022	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888023	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888024	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888025	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888026	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888027	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888028	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888029	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888030	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888031	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888032	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888033	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888034	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888035	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888036	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888037	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888038	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888039	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888040	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888041	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888042	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888043	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888044	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888045	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888046	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888047	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888048	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888049	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888050	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888051	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Active	17888052	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	34.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	34.0
Inactive	17888053	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888054	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888055	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888056	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888057	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888058	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888059	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888060	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888061	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888062	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888063	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888064	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888065	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888066	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888067	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888068	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888069	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888070	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888071	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888072	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888073	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888074	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888075	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888076	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888077	CHEMBL3991647	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5052	Homo sapiens	Kd apparent	nM	30000.0
	18114241	CHEMBL4025253	Inhibition of wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	98.0	CHEMBL5052	Homo sapiens	Activity	%	98.0
	18203777	CHEMBL4044064	Inhibition of wild-type human partial length MRCKB (L56 to S417 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5052	Homo sapiens	Activity	%	100.0
	18253261	CHEMBL4054914	Inhibition of human MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	29.0	CHEMBL5052	Homo sapiens	Activity	%	29.0
	18253262	CHEMBL4054914	Inhibition of human MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	82.0	CHEMBL5052	Homo sapiens	Activity	%	82.0
	18275100	CHEMBL4118412	Inhibition of MRCKb in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPDNVLLDVNGHIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-56.5	CHEMBL5052	Homo sapiens	INH	%	-56.5
	18275101	CHEMBL4118412	Inhibition of MRCKb in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPDNVLLDVNGHIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-52.7	CHEMBL5052	Homo sapiens	INH	%	-52.7
	18275102	CHEMBL4118412	Inhibition of MRCKb in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPDNVLLDVNGHIR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-76.6	CHEMBL5052	Homo sapiens	INH	%	-76.6
	18440319	CHEMBL4157143	Binding affinity to wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	93.0	CHEMBL5052	Homo sapiens	Activity	%	93.0
	18484275	CHEMBL4185922	Binding affinity to wild-type human partial length MRCKB (L56 to S417 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	96.0	CHEMBL5052	Homo sapiens	Activity	%	96.0
	18484759	CHEMBL4185922	Binding affinity to wild-type human partial length MRCKB (L56 to S417 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	98.0	CHEMBL5052	Homo sapiens	Activity	%	98.0
	18507695	CHEMBL4191069	Inhibition of recombinant human MRCKbeta (1 to 473 residues) at 1 uM using KKRNRTLTV as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-4.0	CHEMBL5052	Homo sapiens	INH	%	-4.0
	18653513	CHEMBL4230147	Inhibition of MRCK-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-1.0	CHEMBL5052	Homo sapiens	INH	%	-1.0
	18653514	CHEMBL4230147	Inhibition of MRCK-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	1.0	CHEMBL5052	Homo sapiens	INH	%	1.0
	18655413	CHEMBL4230822	Binding affinity to wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	99.0	CHEMBL5052	Homo sapiens	Activity	%	99.0
	18693969	CHEMBL4253422	Inhibition of recombinant human His-tagged CDC42 BPB expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	15.0	CHEMBL5052	Homo sapiens	INH	%	15.0
	18694051	CHEMBL4253504	Inhibition of recombinant human His-tagged CDC42 BPB expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	68.0	CHEMBL5052	Homo sapiens	INH	%	68.0
	18751048	CHEMBL4263866	Inhibition of MRCK-BETA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	0.0	CHEMBL5052	Homo sapiens	INH	%	0.0
	18751986	CHEMBL4264411	Binding affinity to wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL5052	Homo sapiens	Activity	%	100.0
	18858075	CHEMBL4307921	Binding affinity to wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	85.0	CHEMBL5052	Homo sapiens	Activity	%	85.0
	18892918	CHEMBL4314884	Inhibition of recombinant human MRCKbeta (1 to 473 residues) assessed as residual activity at 10 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	112.5	CHEMBL5052	Homo sapiens	Activity	%	112.5
	18938109	CHEMBL4327781	Inhibition of human MRCKbeta assessed as residual activity at 1 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	96.21	CHEMBL5052	Homo sapiens	Activity	%	96.21
	18938110	CHEMBL4327781	Inhibition of human MRCKbeta assessed as residual activity at 1 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.1	CHEMBL5052	Homo sapiens	Activity	%	96.1
	18938626	CHEMBL4328145	Inhibition of human MRCKbeta assessed as residual activity at 100 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5052	Homo sapiens	Activity	%	65.0
	18939006	CHEMBL4328509	Inhibition of human MRCKbeta using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.75	CHEMBL5052	Homo sapiens	IC50	10'-9M	4.75
	18958763	CHEMBL4333508	Binding affinity to wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	90.0	CHEMBL5052	Homo sapiens	Activity	%	90.0
	18964485	CHEMBL4335182	Inhibition of recombinant human MRCKbeta (1 to 473 residues) assessed as residual activity at 1 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	94.0	CHEMBL5052	Homo sapiens	Activity	%	94.0
	18964486	CHEMBL4335182	Inhibition of recombinant human MRCKbeta (1 to 473 residues) assessed as residual activity at 1 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	110.0	CHEMBL5052	Homo sapiens	Activity	%	110.0
	18971997	CHEMBL4337007	Inhibition of recombinant human MRCKbeta (1 to 473 residues) assessed as residual activity at 10 uM using KKRNRTLTV as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	105.0	CHEMBL5052	Homo sapiens	Activity	%	105.0
Not Active	19039683	CHEMBL4351959	Inhibition of recombinant human MRCKbeta (1 to 473 residues) at 10 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5052	Homo sapiens	INH		
Active	19041192	CHEMBL4352453	Inhibition of human MRCKbeta at 10 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5052	Homo sapiens	INH		
	19059699	CHEMBL4358000	Binding affinity to wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5052	Homo sapiens	Activity	%	100.0
	19090264	CHEMBL4365838	Inhibition of wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5052	Homo sapiens	Activity	%	100.0
	19092019	CHEMBL4366493	Inhibition of human MRCKbeta at 100 nM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	2.9	CHEMBL5052	Homo sapiens	INH	%	2.9
	19144659	CHEMBL4377675	Inhibition of recombinant human MRCKbeta (1 to 473 residues) at 1 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	7.0	CHEMBL5052	Homo sapiens	INH	%	7.0
	19147944	CHEMBL4379262	Inhibition of recombinant human MRCKbeta (1 to 473 residues) using KKRNRTLTV as substrate incubated for 40 mins in presence of [gamma-33ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5052	Homo sapiens	IC50	uM	10.0
	19159527	CHEMBL4382631	Binding affinity to wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	100.0	CHEMBL5052	Homo sapiens	Activity	%	100.0
	19191480	CHEMBL4389350	Inhibition of wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	90.0	CHEMBL5052	Homo sapiens	INH	%	90.0
	19192013	CHEMBL4389827	Inhibition of wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL5052	Homo sapiens	INH	%	100.0
	19200269	CHEMBL4391453	Binding affinity to wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	99.0	CHEMBL5052	Homo sapiens	Activity	%	99.0
	19266515	CHEMBL4405465	Inhibition of wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5052	Homo sapiens	INH	%	50.0
	19276051	CHEMBL4408054	Inhibition of recombinant human MRCKbeta (1 to 473 residues) at 1 uM using KKRNRTLTV as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	7.0	CHEMBL5052	Homo sapiens	INH	%	7.0
	20598202	CHEMBL4602929	Inhibition of human MRCKbeta	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL5052	Homo sapiens	IC50	uM	1.0
	20600480	CHEMBL4603269	Inhibition of recombinant human His-tagged MRCKB catalytic domain expressed in baculovirus expression system using serine/threonine-13 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5052	Homo sapiens	IC50	uM	100.0
	22423435	CHEMBL4674293	Inhibition of human MRCKbeta using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	96.27	CHEMBL5052	Homo sapiens	Activity	%	96.27
	22423436	CHEMBL4674293	Inhibition of human MRCKbeta using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	89.98	CHEMBL5052	Homo sapiens	Activity	%	89.98
	22843658	CHEMBL4720644	Inhibition of human MRCKbeta using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.727	CHEMBL5052	Homo sapiens	IC50	10^-10M	7.27
	22844007	CHEMBL4720993	Inhibition of human MRCKbeta assessed as residual activity using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	96.36	CHEMBL5052	Homo sapiens	Activity	%	96.36
	22844763	CHEMBL4721438	Inhibition of wild-type human partial length MRCKB (L56 to S417 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	97.98	CHEMBL5052	Homo sapiens	Activity	%	97.98
	22952912	CHEMBL4766849	Inhibition of recombinant human MRCKbeta (1 to 473 residues) assessed as residual activity at 10 uM using KKRNRTLTV as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	106.0	CHEMBL5052	Homo sapiens	Activity	%	106.0
	23122684	CHEMBL4805035	Inhibition of human MRCKB assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL5052	Homo sapiens	Activity	%	100.0
	23123379	CHEMBL4805623	Inhibition of human MRCKB assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	92.0	CHEMBL5052	Homo sapiens	Activity	%	92.0
	23123838	CHEMBL4806082	Inhibition of DNA-tagged human MRCKB assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	83.0	CHEMBL5052	Homo sapiens	Activity	%	83.0
	23124848	CHEMBL4806640	Inhibition of human MRCKB assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL5052	Homo sapiens	Activity	%	96.0
	23124849	CHEMBL4806640	Inhibition of human MRCKB assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5052	Homo sapiens	Activity	%	100.0
	23127882	CHEMBL4807769	Inhibition of CDC42BPB (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5052	Homo sapiens	Activity	%	75.0
	23127883	CHEMBL4807769	Inhibition of CDC42BPB (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5052	Homo sapiens	Activity	%	75.0
	23127884	CHEMBL4807769	Inhibition of CDC42BPB (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5052	Homo sapiens	Activity	%	75.0
Not Active	23317520	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23317988	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	69.0	CHEMBL5052	Homo sapiens	% Control	%	69.0
Not Active	23318655	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	76.0	CHEMBL5052	Homo sapiens	% Control	%	76.0
Not Active	23319138	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	95.0	CHEMBL5052	Homo sapiens	% Control	%	95.0
Not Active	23319775	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23320250	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23320928	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23321396	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23322026	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	87.0	CHEMBL5052	Homo sapiens	% Control	%	87.0
Not Active	23322494	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	97.0	CHEMBL5052	Homo sapiens	% Control	%	97.0
Not Active	23323183	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23323651	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23324066	CHEMBL4880685	MRCKbeta (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-7.0	CHEMBL5052	Homo sapiens	% inhibition	%	-7.0
Not Active	23324505	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23325140	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23325608	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	96.0	CHEMBL5052	Homo sapiens	% Control	%	96.0
Not Active	23326255	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23326723	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	62.0	CHEMBL5052	Homo sapiens	% Control	%	62.0
Not Active	23327423	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23327891	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23328478	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23328946	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	96.0	CHEMBL5052	Homo sapiens	% Control	%	96.0
Not Active	23329430	CHEMBL4881137	MRCKbeta (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	110.0	CHEMBL5052	Homo sapiens	% residual kinase activity	%	110.0
Not Active	23329892	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23330360	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23331116	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23331584	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23332171	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	95.5	CHEMBL5052	Homo sapiens	% Control	%	95.5
Not Active	23332637	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23333355	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23333994	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	89.0	CHEMBL5052	Homo sapiens	% Control	%	89.0
Not Active	23334462	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23335441	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	70.0	CHEMBL5052	Homo sapiens	% Control	%	70.0
Not Active	23335909	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23336536	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23337004	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	82.0	CHEMBL5052	Homo sapiens	% Control	%	82.0
Not Active	23337536	CHEMBL4881907	CDC42 BPB Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	94.0	CHEMBL5052	Homo sapiens	% Ctrl	%	94.0
Not Active	23338085	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	99.0	CHEMBL5052	Homo sapiens	% Control	%	99.0
Not Active	23338553	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	85.0	CHEMBL5052	Homo sapiens	% Control	%	85.0
Not Active	23339165	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23339633	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	99.0	CHEMBL5052	Homo sapiens	% Control	%	99.0
Not Active	23340270	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23340738	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	95.0	CHEMBL5052	Homo sapiens	% Control	%	95.0
Not Active	23341395	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23341863	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23342479	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	81.0	CHEMBL5052	Homo sapiens	% Control	%	81.0
Not Active	23342947	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23343577	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	88.0	CHEMBL5052	Homo sapiens	% Control	%	88.0
Not Active	23344045	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23344683	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	89.0	CHEMBL5052	Homo sapiens	% Control	%	89.0
Not Active	23345256	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	96.0	CHEMBL5052	Homo sapiens	% Control	%	96.0
Not Active	23345724	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23346301	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23346769	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	91.6	CHEMBL5052	Homo sapiens	% Control	%	91.6
Not Active	23347371	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	99.8	CHEMBL5052	Homo sapiens	% Control	%	99.8
Not Active	23347861	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23348440	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23348908	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	81.0	CHEMBL5052	Homo sapiens	% Control	%	81.0
Not Active	23349495	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23350113	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23350581	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23351186	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23351654	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23351985	CHEMBL4882678	CDC42 BPB (MRCKB) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	4.343	CHEMBL5052	Homo sapiens	% Inhibition	%	4.3432
Not Active	23352678	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	93.0	CHEMBL5052	Homo sapiens	% Control	%	93.0
Not Active	23353146	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23354028	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23354496	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23355228	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23355696	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	99.0	CHEMBL5052	Homo sapiens	% Control	%	99.0
Not Active	23356332	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23356800	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23357409	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	94.0	CHEMBL5052	Homo sapiens	% Control	%	94.0
Not Active	23358056	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23358524	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23359110	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	99.5	CHEMBL5052	Homo sapiens	% Control	%	99.5
Not Active	23359708	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	85.0	CHEMBL5052	Homo sapiens	% Control	%	85.0
Not Active	23360176	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23360761	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	94.0	CHEMBL5052	Homo sapiens	% Control	%	94.0
Not Active	23361229	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	95.0	CHEMBL5052	Homo sapiens	% Control	%	95.0
Not Active	23361802	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23362338	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Slightly Active	23362806	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	39.0	CHEMBL5052	Homo sapiens	% Control	%	39.0
Not Active	23364448	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23364916	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	94.0	CHEMBL5052	Homo sapiens	% Control	%	94.0
Not Active	23365655	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	87.0	CHEMBL5052	Homo sapiens	% Control	%	87.0
Not Active	23366198	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	88.0	CHEMBL5052	Homo sapiens	% Control	%	88.0
Not Active	23366788	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23367256	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23367494	CHEMBL4883847	CDC42BPB ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	83.0	CHEMBL5052	Homo sapiens	% Residual activity with Skepinone-L	%	83.0
Not Active	23368134	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	73.0	CHEMBL5052	Homo sapiens	% Control	%	73.0
Not Active	23368602	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	88.0	CHEMBL5052	Homo sapiens	% Control	%	88.0
Not Active	23369201	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23369669	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	96.0	CHEMBL5052	Homo sapiens	% Control	%	96.0
Not Active	23370148	CHEMBL4884392	MRCKbeta(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	109.0	CHEMBL5052	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23370637	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23371105	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23371914	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23372382	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	90.0	CHEMBL5052	Homo sapiens	% Control	%	90.0
Not Active	23375809	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	90.0	CHEMBL5052	Homo sapiens	% Control	%	90.0
Not Active	23376277	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23376854	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23377322	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23378182	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	73.0	CHEMBL5052	Homo sapiens	% Control	%	73.0
Not Active	23378650	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	80.0	CHEMBL5052	Homo sapiens	% Control	%	80.0
Not Active	23379817	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	96.0	CHEMBL5052	Homo sapiens	% Control	%	96.0
Not Active	23380285	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	63.0	CHEMBL5052	Homo sapiens	% Control	%	63.0
Not Active	23380979	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23381627	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23382095	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23382719	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	90.0	CHEMBL5052	Homo sapiens	% Control	%	90.0
Not Active	23383187	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL5052	Homo sapiens	% Control	%	100.0
Not Active	23383724	CHEMBL4887373	CDC42 BPB Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	103.0	CHEMBL5052	Homo sapiens	% Ctrl	%	103.0
Not Active	23384359	CHEMBL4887954	MRCKbeta(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-15.79	CHEMBL5052	Homo sapiens	% inhibition	%	-15.79
Not Active	23384641	CHEMBL4888167	CDC42 BPB (MRCKB) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	1.0	CHEMBL5052	Homo sapiens	% Inhibition	%	1.0
Not Active	23385102	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	81.0	CHEMBL5052	Homo sapiens	% Control	%	81.0
Not Active	23385569	CHEMBL4879826	KinomeScan assay: inhibition of MRCKB	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	89.0	CHEMBL5052	Homo sapiens	% Control	%	89.0
